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ABSTRACT

Resistance exercise eliciting muscle damage results in an immune response, leading to
increases in circulating cytokines, and immune cell mobilization. Classical monocytes
respond to muscle damage, however, little is known about the intermediate or nonclassical
monocyte response to resistance exercise.

Moreover, the impact of polyphenol

supplementation in conjunction with resistance exercise on the innate immune response is
unknown. The purpose of this study was to examine the immune response following
resistance exercise with (PPB) and without (PL) polyphenol supplementation. Thirty-nine
untrained men were randomized into three groups: PPB (n=13, 21.8±2.5yrs, 171.2±5.5cm,
71.2±8.2kg), PL (n=15, 21.6±2.5yrs, 176.5±4.9cm, 84.0±15.7kg) or a control group (CON)
(23.3±4.1yrs, 173.6±12.0cm, 77.8±15.6kg). Blood samples were obtained pre- (PRE),
immediately- (IP), 1- (1H), 5- (5H), 24- (24H), 48- (48H) and 96- (96H) hours postexercise (PPB/PL). CON rested for one hour between PRE and IP blood draws. Changes
in granulocyte and monocyte subset proportions and adhesion characteristics (CD11b)
were assessed via flow cytometry, while plasma cytokine concentrations and markers of
muscle damage were analyzed via multiplex and spectrophotometric assays, respectively.
Creatine Kinase and myoglobin were elevated at each time point for PPB and PL (p <
0.050). Monocyte chemoattractant protein-1 was significantly elevated at IP in PPB (p =
0.005) and PL (p = 0.006) and significantly greater than CON at 5H (PPB: p < 0.001; PL:
p = 0.006). Granulocyte proportions were elevated at 1H (p < 0.001), 5H (p < 0.001) and
24H (p = 0.005; p = 0.006) in PPB and PL, respectively. Classical monocyte proportions
were lower in PPB (p = 0.008) and PL (p = 0.003) than CON at IP, and significantly greater
iii

than CON at 1H (PPB: p = 0.002; PL: p = 0.006). Nonclassical monocyte proportions were
significantly greater in PPB (p = 0.020) and PL (p = 0.028) than CON at IP. Intermediate
monocyte proportions were significantly greater in PPB (p = 0.034) and PL (p = 0.001)
than CON at IP, and significantly lower than CON at 1H (PPB: p = 0.003; PL: p = 0.008).
Intermediate monocyte proportions were also significantly greater in PPB than CON at
24H (p = 0.016) and 48H (p = 0.007). At PRE, CD11b expression was significantly lower
in the PPB group than CON and PL for intermediate (p = 0.017; p = 0.045) and nonclassical
(p < 0.001, p = 0.019) monocytes, respectively. When groups were combined, CD11b
expression was significantly elevated from PRE at IP (p < 0.001) and 1H (p = 0.015) on
granulocytes.

CD11b expression on classical monocytes was significantly elevated

compared to PRE at 1H (p < 0.001), 5H (p = 0.033) and 24H (p = 0.004) when groups were
combined. CD11b expression on intermediate monocytes was significantly elevated
compared to PRE at 1H (p < 0.001) when groups were combined. Intermediate and
nonclassical monocyte proportions also showed significant positive correlations with
markers of muscle damage (r = 0.361 to 0.775, p<0.05). Results indicated that resistance
exercise in novice lifters may elicit a selective mobilization of intermediate monocytes at
24h and 48H, and that muscle damage may be related to increases in intermediate and
nonclassical monocytes. In addition, polyphenol supplementation appeared to suppress
CD11b expression on monocytes to resistance exercise.
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CHAPTER 1: INTRODUCTION

Resistance exercise performed at a sufficient intensity will result in microtrauma to skeletal
muscle, which may be reflected by leakage of various biomarkers from the sarcolemma
(e.g., creatine kinase or myoglobin), increases in muscle soreness and potential decreases
in muscle performance (Clarkson & Hubal, 2002; Jajtner et al., 2015; Paulsen et al., 2005).
The mechanical stress associated with the exercise stimulus and the resulting tissue damage
signals a profound non-specific immune response (Calle & Fernandez, 2010). This
response manifests itself through increases in cytokine and chemokine production from
skeletal muscle tissue, endothelial cells, resident macrophages, and other circulating
immune cells (Ancuta, Moses, & Gabuzda, 2004; Ancuta et al., 2003; Brigitte et al., 2010;
Della Gatta, Cameron-Smith, & Peake, 2014; Nieman et al., 2004). Once released,
cytokines and chemokines will elicit a response from the innate immune system, resulting
in an accumulation of myeloid cells within a few hours and persist for several days
following the muscle damaging exercise protocol (Paulsen et al., 2010).
The infiltration of damaged tissue consists of three phases; preliminary, early and
late, with each phase eliciting specific actions within the recovery process (Tidball &
Villalta, 2010). The preliminary phase primarily consists of neutrophil infiltration to the
site of damage, which promotes an inflammatory environment (Nguyen & Tidball, 2003b;
Pizza, Peterson, Baas, & Koh, 2005). Subsequently, during the early phase monocytes
become mobilized and differentiate into pro-inflammatory (M1) macrophages replacing
neutrophils, further propagating the inflammatory environment (Chazaud, 2014; Nguyen
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& Tidball, 2003a; Rigamonti et al., 2013; Song et al., 2000). M1 macrophages then will
yield to anti-inflammatory (M2) macrophages, which exhibit regenerative roles during the
late phase of recovery (Chazaud, 2014; Song et al., 2000; Tidball & Villalta, 2010).
Neutrophils and monocytes are preferentially recruited by specific chemokines, namely
interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and fractalkine
(CX3CL1) (Ancuta et al., 2003; Hammond et al., 1995; Yadav, Saini, & Arora, 2010).
Although macrophages are derived from circulating monocytes (Yang, Zhang, Yu, Yang,
& Wang, 2014), evidence suggests that certain monocyte subsets typically give rise to M1
macrophages, while others differentiate into M2 macrophages (Ancuta et al., 2003; Auffray
et al., 2007).
Recently, monocytes have been formally organized into a three subset paradigm
(Ziegler-Heitbrock et al., 2010), replacing the two subset model from the late 1980’s
(Wong et al., 2012). Phenotypically, monocytes are identified based on their expression
of the lipopolysaccharide (LPS) receptor, CD14 and the FcγRIIIa receptor, CD16. Briefly,
classical

(CD14++/CD16-),

intermediate

(CD14++/CD16+)

and

nonclassical

(CD14+/CD16++) monocytes exhibit different behaviors within the circulation (Van
Craenenbroeck et al., 2014). Classical monocytes display phagocytic behavior, while
intermediate monocytes exhibit inflammatory actions and function as antigen presenting
cells (Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011). Nonclassical monocytes
are patrolling cells residing primarily within the marginal pool monitoring the endothelium
(Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011). With the varied responsibilities
of each monocyte subset, healthy individuals typically maintain 80-90% classical
monocytes, 5-10% intermediate monocytes and 5-10% nonclassical monocytes (Yang et
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al., 2014). During disease and inflammatory states, the proportion of these subsets are
altered (Poehlmann, Schefold, Zuckermann-Becker, Volk, & Meisel, 2009; Tallone et al.,
2011; Zhu et al., 2015).
Exercise elicits an inflammatory environment, which prompts modulation of the
monocyte subsets (LaVoy et al., 2015; Shantsila et al., 2012). Typically, the response to
exercise entails a significant decrease in the proportion of classical monocytes with a
concomitant increase in the proportion of nonclassical monocytes immediately following
exercise (Booth et al., 2010; Radom-Aizik, Zaldivar, Haddad, & Cooper, 2014; Shantsila
et al., 2012; Simpson et al., 2009). Within one hour of recovery, the subsets have been
demonstrated to return to resting levels (Booth et al., 2010), or flip responses, with an
increased proportion of classical monocytes and decreases in the proportion of both
intermediate and nonclassical monocytes (Simpson et al., 2009). To the best of our
knowledge, no studies have investigated the effect of resistance exercise on monocytes
subsets. Ischemic conditions that elicit acute tissue damage, such as stroke and myocardial
infarction, have demonstrated relationships with changes in intermediate monocytes and
markers of tissue damage (Tapp, Shantsila, Wrigley, Pamukcu, & Lip, 2012; Urra et al.,
2009). Although speculative, a mechanical stress such as resistance exercise, which can
result in skeletal muscle damage, may induce a similar response.
While changes in leukocyte subsets are observed following exercise (Booth et al.,
2010; J. M. Peake, K. Suzuki, G. Wilson, et al., 2005), changes in cellular activation have
also been demonstrated (Jajtner et al., 2014; Nielsen & Lyberg, 2004; van Eeden, Granton,
Hards, Moore, & Hogg, 1999; Wells et al., 2016). Macrophage-1 Antigen (MAC1), also
referred to as Complement receptor 3 (CR3), is a β2 integrin involved in the late phases of
3

transendothelial migration of immune cells following tissue damage (Tan, 2012).
Investigations examining the MAC1/CR3 response on both neutrophils and monocytes
have utilized various modes of exercise (Jajtner et al., 2014; Nielsen & Lyberg, 2004; van
Eeden et al., 1999; Wells et al., 2016). The MAC1/CR3 response to resistance exercise on
neutrophils has yielded primarily equivocal results (J. M. Peake, K. Suzuki, G. Wilson, et
al., 2005; Pizza et al., 1996; Saxton, Claxton, Winter, & Pockley, 2003). However, changes
in the MAC1/CR3 expression on monocytes appear to be more consistent, characterized
by an increase in expression for up to one hour post-exercise (Gonzalez et al., 2014; Jajtner
et al., 2014; Wells et al., 2016). These latter results, though, did not examine the response
of MAC1/CR3 on different monocyte subsets.

Limited research has suggested that

classical monocytes may have a more robust response to exercise than the other monocyte
subsets (Hong & Mills, 2008).
As resistance exercise appears to elicit significant elevations in markers of
oxidative stress (Merry & Ristow, 2015; Urso & Clarkson, 2003), antioxidant
supplementation has been examined as a potential countermeasure to reduce the oxidative
response to resistance exercise (Bowtell, Sumners, Dyer, Fox, & Mileva, 2011; Jowko et
al., 2011; Panza et al., 2008; Paulsen et al., 2014).

Specifically, polyphenol

supplementation has been demonstrated to reduce force deficits and markers of muscle
damage in response to resistance exercise (Bowtell et al., 2011; Jowko et al., 2011; Panza
et al., 2008) while others have demonstrated equivocal results (Paulsen et al., 2014).
Furthermore, the cytokine/chemokine response following endurance exercise and vitamin
A, C and E supplementation has demonstrated a blunted response of the pro-inflammatory
cytokines IL-1β, IL-6 and TNF-α (Vassilakopoulos et al., 2003). However, the benefits of
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polyphenol supplementation in conjunction with eccentric exercise have been ambiguous
(Herrlinger, Chirouzes, & Ceddia, 2015; Kerksick, Kreider, & Willoughby, 2010; O'Fallon
et al., 2012). Decreases in circulating neutrophil concentrations have been observed 48
hours following eccentric exercise in conjunction with epigallocatechin gallate (EGCG)
supplementation (Kerksick et al., 2010), however, the fate of these cells are unknown. As
polyphenol incubation results in reduced expression of adhesion molecules on neutrophils
and monocytes, along with limited chemotaxis in vitro (Graff & Jutila, 2007; Kawai et al.,
2004; Takano, Nakaima, Nitta, Shibata, & Nakagawa, 2004) decreased neutrophil
concentrations following exercise is not likely explained by increased infiltration. To the
best of our knowledge, the specific response of neutrophils and monocyte activation
following polyphenol supplementation and resistance exercise is not well understood.
Therefore, the primary purpose of this investigation was to examine the response
of neutrophils and monocyte subtype proportion and activation to an acute bout of
resistance exercise following 28-days of polyphenol supplementation. Furthermore, a
secondary purpose of this study was to investigate the impact of polyphenol
supplementation on leukocyte recruitment, behavior, and activation as well as functional
recovery in response to resistance exercise.
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CHAPTER 2: REVIEW OF LITERATURE

The immune system is composed to two primary arms; the adaptive immune system (or
specific immunity) and the innate immune system. Both arms function to maintain the
health and integrity of the individual, yet have distinct responsibilities (Parkin & Cohen,
2001). While adaptive immunity can be characterized as a small, but specific response,
requiring prior sensitization to the pathogen, innate immunity is characterized by a
profound, non-specific response that becomes prominent upon the first encounter with the
pathogen (Parkin & Cohen, 2001). While both adaptive and innate immunity are active
during and after exercise, the innate immune system plays a primary role in recovery from
muscle damaging exercise.
Exercise resulting in muscle damage will initiate an inflammatory cascade that
recruits immune cells, primarily neutrophils and monocytes, to the site of damage through
the process of chemotaxis (Calle & Fernandez, 2010; Freidenreich & Volek, 2012). When
cells arrive at the site of damage they begin the process of diapedesis, and extravasation
(Ley, Laudanna, Cybulsky, & Nourshargh, 2007), of which the β2 integrin macrophage-1
antigen (MAC-1), also known as complement receptor-3 (CR3), plays a major role (Ehlers,
2000; Ley et al., 2007; Tan, 2012). Once at the site of tissue injury, immune cells complete
a variety of tasks to promote healing of the damaged tissue.
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Cytokine Signaling of Immune Cells
For the purposes of this review, a brief overview of cytokine function and
classification will be given; however, the function of specific cytokines within the immune
response to resistance exercise will be discussed in the later sections. Cytokines are small
proteins that are responsible for communication between immune cells (Nicod, 1993).
Cytokines are also produced by a variety of cells, including leukocytes and skeletal muscle
cells during and following exercise (Calle & Fernandez, 2010). As cytokines are signaling
molecules, they are classified based on the type of response they propagate, either proinflammatory or anti-inflammatory (Pedersen, 2000). Furthermore, cytokines can be
broken into subsets based on their structure, and/or function. Although there is some
overlap between the classifications, the most notable cytokine subsets are interleukins (e.g.
IL-1β, IL-6) and chemokines (Nicod, 1993). Briefly, interleukin (“inter” – between;
“leukin” – leukocyte) is an umbrella term to classify signaling molecules that mediate
communication between leukocytes (Nicod, 1993).
Chemokines serve as chemotactic agents, attracting leukocytes to the site of
damage (Nicod, 1993). Furthermore, chemokines are classified into four main subsets
based on their protein structure, namely, the position of the first two cysteine molecules
near the N-terminus (Rollins, 1997). The three most common chemokine subsets within
the immune response to resistance exercise are the CC (β-chemokines), CXC (αchemokines), and the CX3C chemokines (Nicod, 1993; Rollins, 1997). Briefly, a CC
chemokine positions two cysteine molecules adjacent to one another, while 1 or 3
additional amino acids are positioned between the first and second cysteines of CXC or
7

CX3C chemokines, respectively (Rollins, 1997).

Therefore, the nomenclature for

chemokines is based on the structure at the N-terminus, followed by the receptor or ligand
number. For instance, the chemokine CCL2 (also referred to as MCP-1) is ligand 2 of the
CC chemokine family, while CX3CR1 is receptor 1 of the CX3C chemokine family.

Immune cells Involved in the Inflammatory Response
Leukocytes are the cells that make up the immune system, and are classified into
three major populations: lymphocytes, monocytes, and granulocytes. Lymphocytes are
sub-divided into T-, B- and natural killer (NK) cells, which collectively make up
approximately 25% of total leukocytes in healthy individuals (Roussel, Benard, LySunnaram, & Fest, 2010). Monocytes make up 5-10% of total leukocytes in healthy
populations, and give rise to dendritic cells (DC) (Roussel et al., 2010; Ziegler-Heitbrock
et al., 2010). Granulocytes are further divided into three cell types: neutrophils, basophils
and eosinophils (Roussel et al., 2010). In healthy individuals, neutrophils make up 50-70%
of the total leukocyte population, while eosinophils and basophils make up approximately
1-5% and <1%, respectively (Roussel et al., 2010). In general, lymphocytes, namely Tand B- cells make up the adaptive immune system, while monocytes, granulocytes and NK
cells make up the innate immune system (Parkin & Cohen, 2001).
Development of leukocytes derive from hematopoietic stem cells (HSC), while
lymphocytes develop through a common lymphoid progenitor (CLP), and the lymphoid
pathway (Akashi, Traver, Miyamoto, & Weissman, 2000). Monocytes and granulocytes
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develop through the myeloid pathway, with a common myeloid progenitor (CMP), and a
granulocyte/macrophage precursor (GMP) (Akashi et al., 2000; Summers et al., 2010).
Following differentiation to the GMP, granulocytes and monocytes are developed by
separate pathways. Granulocytes continue to develop through granulocytic progenitor
cells in the mitotic pool before developing into mature immune cells in the post-mitotic
pool (Summers et al., 2010). Within the bone marrow, monocytes continue to mature into
macrophage/DC precursors followed by the commited monocyte progenitor (cMoP), and
then develop into monocytes (Mitchell, Roediger, & Weninger, 2014).

Granulocytes
Granulocytes are broken into three distinct cell types: neutrophils, basophils and
eosinophils. Neutrophils are the most numerous leukocyte, and within the context of
muscle damage, are the most active granulocyte (Kolaczkowska & Kubes, 2013; Tidball,
2005). Mobilization of neutrophils from the bone marrow is stimulated by granulocyte
colony stimulating factor (G-CSF) (Sadik, Kim, & Luster, 2011; Semerad, Liu, Gregory,
Stumpf, & Link, 2002), while recruitment to damaged tissue is mediated by interactions
with endothelial cells and specific cytokines (Kolaczkowska & Kubes, 2013; Ribeiro,
Flores, Cunha, & Ferreira, 1991). The cell surface receptors on neutrophils responsible for
the cytokine-mediated recruitment are the CXC chemokine receptors 1 and 2 (CXCR1 and
CXCR2) (Futosi, Fodor, & Mocsai, 2013; Hammond et al., 1995), which bind interleukin8 (IL-8; CXCL8), a potent chemoattractant of neutrophils (Ribeiro et al., 1991; Sadik et
al., 2011). Furthermore, recruitment of neutrophils by endothelial interaction is mediated
9

by adhesion receptors (Kolaczkowska & Kubes, 2013). Neutrophils express several
adhesion receptors, including L-selectin (CD62L), P-selectin glycoprotein ligand-1
(PSGL-1), lymphocyte function-associate antigen 1 (LFA-1) and MAC1/CR3 (Futosi et
al., 2013). Each of these adhesion molecules perform prominent roles in the leukocyte
adhesion cascade, which will be discussed in more detail later (Kolaczkowska & Kubes,
2013; Ley et al., 2007).
Following recruitment, neutrophils are the first cells to arrive at the site of
inflammation following a bout of resistance exercise (Tidball & Villalta, 2010). Within
damaged tissue, neutrophils exhibit a multitude of functions, including phagocytosis,
degranulation, and the release of neutrophil extracellular traps (NETs) (Kolaczkowska &
Kubes, 2013). The phagocytic response of the neutrophil is represented by the expression
of phagocytic receptors, namely the Fc receptors cluster of differentiation- (CD) 64 and
CD16, as well as complement receptors on the cell surface (Dale, Boxer, & Liles, 2008;
Futosi et al., 2013). Briefly, during phagocytosis, the neutrophil recognizes opsonized
debris, engulfs and then sequesters the debris into a phagosome (Dale et al., 2008;
Kolaczkowska & Kubes, 2013). Once the cellular debris is isolated, granules within the
cytosol of the neutrophil will fuse to the phagosome, releasing enzymes to degrade the
debris (Kolaczkowska & Kubes, 2013; Nguyen & Tidball, 2003b; Tidball, 2005).
Myeloperoxidase (MPO), released from the primary granules, and nicotinamide
adenine dinucleotide phosphate-oxidase (NADPH oxidase) are two important enzymes
contained within neutrophils (Kolaczkowska & Kubes, 2013; Tidball, 2005). During
phagocytosis, as granules fuse to the phagosome, they also fuse to the cell membrane, and
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release their contents into the phagosome, or extracellular space (Kolaczkowska & Kubes,
2013; Nguyen & Tidball, 2003b; Tidball, 2005). Once the enzymes are released, a
cytotoxic environment is promoted in the phagosome and extracellular space through a
specific pathway depicted in Figure 1 (Nguyen & Tidball, 2003b; Tidball, 2005). Briefly,
neutrophils consume oxygen that reacts with NADPH oxidase to produce superoxide
(Hampton, Kettle, & Winterbourn, 1998). Superoxide can be converted to hydrogen
peroxide, by superoxide dismutase, which in turn is converted to hypochlorous acid by
MPO, prompting cytolytic effects (Hampton et al., 1998; Kolaczkowska & Kubes, 2013;
Tidball, 2005) (Figure 1).

Figure 1: Secondary Damage by Neutrophils.
Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) serves as
the precursor to superoxide. Superoxide dismutase (SOD) served as an
intermediary, catalyze the conversion to hydrogen peroxide (H2O2).
Myeloperoxidase catalyzes the reaction to hypochlorous acid (HOCl), which will
induce skeletal muscle damage.
Adapted from: Tidball (2005)
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The cytotoxic environment produced will prompt additional injury to the skeletal
muscle, a process known as secondary damage (Nguyen & Tidball, 2003b; Pizza et al.,
2005; Tidball, 2005). This secondary damage caused by neutrophils is enhanced later in
recovery, through synergistic action with macrophages (Nguyen & Tidball, 2003a).
Nonetheless, researchers have demonstrated that neutrophil mediated secondary damage is
not necessary to maintain myofibril recovery, or macrophage populations in the murine
model (Nguyen & Tidball, 2003b; Pizza et al., 2005).

However, others argue that

neutrophils may provide protective effects to skeletal muscle, despite promoting secondary
damage (Lockhart & Brooks, 2008; Teixeira et al., 2003; Tidball, 2005). In the human
model, neutrophil-mediated secondary damage has been suggested to enhance recruitment
of circulating monocytes (Soehnlein, Lindbom, & Weber, 2009). Furthermore, MPO
appears to enhance the phagocytic activity of CD68, a significant receptor of macrophages,
leading to enhanced macrophage activation (Kolaczkowska & Kubes, 2013; Tidball &
Villalta, 2010; Zouaoui Boudjeltia et al., 2004). Therefore, it appears that neutrophils may
not be necessary for recovery, however, may aid in the recovery process.

Monocytes
For nearly 25 years, monocytes, which make up approximately 5-10% of the total
circulating leukocyte population (Booth et al., 2010; Hong & Mills, 2008), have been subdivided into two primary categories, classical and nonclassical monocytes (Wong et al.,
2012; Ziegler-Heitbrock et al., 2010; Ziegler-Heitbrock & Hofer, 2013). Recent work,
however has demonstrated a differential function of the lesser, nonclassical monocyte
12

(Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011). This led to further refinement
of monocytes, and the newly accepted population of intermediate monocytes (ZieglerHeitbrock et al., 2010). These monocyte subsets have been widely identified via flow
cytometry based on their differential expression of the lipopolysaccharide (LPS) receptor,
CD14 and the FcγRIIIa receptor, CD16, as seen in Figure 2 (Wong et al., 2012; ZieglerHeitbrock et al., 2010). Wong and colleagues (2012), among others (Ziegler-Heitbrock et
al., 2010) have previously defined classical monocytes as CD14++/CD16-, intermediate
monocytes as CD14++/CD16+ and nonclassical monocytes as CD14+/CD16++. While
these subsets have at times been referred to as inflammatory and anti-inflammatory,
Ziegler-Heitbrock and colleagues (2010) recommend caution with these labels. They argue
that these terms have been interchanged based on the species (murine vs human), and may
lead to an oversight of important roles for each population (Ziegler-Heitbrock et al., 2010).
Therefore, for the purposes of this review, monocytes will be subdivided into three
categories:

classical

monocytes

(CD14++/CD16-),

intermediate

(CD14++/CD14+) and nonclassical monocytes (CD14+/CD16+).

monocytes

Due to the recent

discrimination between nonclassical and intermediate monocytes, there are limitations on
the studies completed prior to this point. In order to examine these studies, discussion of
the undifferentiated nonclassical population will be referred to as CD16+ monocytes.
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Figure 2: Fluorescent Characteristics of Monocyte Subsets.
Monocytes were analyzed for their differential expression of cluster of
differentiation (CD)-14 and CD16. Monocytes were classified as Classical (Clas),
Intermediate (Inter) or Nonclassical (Non-Clas).

Monocyte Subsets
Classical Monocytes
Classical monocytes remain in circulation for a few days after release from the bone
marrow (Wong et al., 2011; Ziegler-Heitbrock et al., 2010; Ziegler-Heitbrock & Hofer,
2013). It has been suggested that a developmental relationship may exist between classical
monocytes with intermediate and nonclassical monocytes (Ancuta et al., 2009; ZieglerHeitbrock et al., 2010). While there is compelling data demonstrating modulation of key
receptors on monocytes in vitro (Ramos et al., 2010), formal demonstration of a
progressive relationship between monocytes has yet to be provided in humans (Wong et
al., 2012; Ziegler-Heitbrock et al., 2010). Classical monocytes make up the majority of
the monocyte population, ranging between 80 to 90% of the total monocyte population at
rest in healthy individuals (Wong et al., 2011; Ziegler-Heitbrock et al., 2010; Ziegler14

Heitbrock & Hofer, 2013). However, this can be greatly altered in several clinical and nonclinical conditions (Booth et al., 2010; Hristov & Weber, 2011; Rossol, Kraus, Pierer,
Baerwald, & Wagner, 2012; Simpson et al., 2009; Tapp et al., 2012).
In response to LPS-mediated activation, classical monocytes secrete a variety of
chemotactic cytokines, including G-CSF, IL-8, CCL3, CCL5, and MCP-1 in addition to
IL-6 and IL-10 at high levels (Cros et al., 2010; Wong et al., 2011; Wong et al., 2012).
LPS-stimulation also results in pro-inflammatory cytokine (IL-1β and TNFα) production
at moderate levels in classical monocytes (Cros et al., 2010; Wong et al., 2011).
Furthermore, classical monocytes demonstrate a high degree of reactive oxygen species
(ROS) production in response to LPS stimulation, and the highest phagocytic ability of the
three monocyte subsets (Cros et al., 2010; Zawada et al., 2011).
While the secretion of cytokines may explain the potential effects of classical
monocytes on the overall milieu of the adjacent area, examination of receptor expression
on classical monocytes demonstrates the phagocytic role of this subset.

Classical

monocytes express greater levels of CD36 and CD64, which serve as a scavenging receptor
and receptors that initiate phagocytosis, respectively (Cros et al., 2010; Wong et al., 2011;
Zawada et al., 2011). Classical monocytes also express the greatest proportion of the CCR2
(receptor for MCP-1) and CXCR1 and CXCR2 (receptors for IL-8) when compared to
intermediate and nonclassical monocytes (Cros et al., 2010; Wong et al., 2011). Despite
the increased expression of CXCR1 and CXCR2 on classical monocytes, the primary
chemotactic response of this specific subset is mediated by the MCP-1/CCR2 interaction
(Leonard & Yoshimura, 1990; Wong et al., 2012; Yadav et al., 2010; Yang et al., 2014).

15

Interestingly, expression of CX3CR1 is greatly reduced on classical monocytes; a defining
characteristic of classical versus intermediate and nonclassical monocytes (Cros et al.,
2010; Wong et al., 2011).

Finally, classical monocytes are characterized by high

expression of L-selectin (CD62L) and CD11b, which are necessary components of the
adhesion cascade, discussed later (Cros et al., 2010; Wong et al., 2011; Zawada et al.,
2011). Taken together, evidence demonstrates the ability of the classical monocyte to
migrate to the site of tissue damage, cross the endothelial wall, and scavenge/phagocytose
damaged tissue.

Intermediate Monocytes
Intermediate monocytes are the newest subset to be identified, and were formally
labeled in 2010 with the consortium statement put forward by the International Union of
Immunological Societies and the World Health Organization (Ziegler-Heitbrock et al.,
2010). As stated previously, intermediate monocytes appear to have a developmental
relationship between classical and nonclassical (Wong et al., 2012; Ziegler-Heitbrock et
al., 2010), evidenced by the intermediate expression of several receptors and cytokine
production. Typically, intermediate monocytes make up 5-10% of the total circulating
monocytes (Wong et al., 2012; Ziegler-Heitbrock et al., 2010; Ziegler-Heitbrock & Hofer,
2013), although this can vary greatly with clinical conditions (Hristov & Weber, 2011;
Rossol et al., 2012; Tapp et al., 2012).
Intermediate monocyte display elevated expression of CD11b, a characteristic they
share with classical monocytes (Cros et al., 2010; Wong et al., 2012; Zawada et al., 2011).
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However, intermediate monocytes also have positive expression of CX3CR1 (receptor for
CX3CL1) and lack L-Selectin (CD62L), characteristics they share with nonclassical
monocytes (Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011). While intermediate
monocytes have a high capacity for phagocytosis (Cros et al., 2010; Zawada et al., 2011),
ROS production from this subset is controversial. Cros and colleagues (2010) reported
minimal ROS production, while Zawada, et al. (2011) reported the greatest ROS
production from intermediate monocytes. Zawada and colleagues (2011) attribute this
difference to the discrepancies between the sampling techniques used.

Intermediate

monocytes also display an inflammatory function, in addition to functioning as an antigen
presenting cell, while also demonstrating an ability to cross the endothelium into damaged
tissue (Yang et al., 2014).
The inflammatory nature of the intermediate subset is tied to the pro-inflammatory
milieu it promotes. Intermediate monocytes secrete greater amounts of IL-6, and IL-1β,
than any other subset, as well as a moderate amount of IL-8 and IL-10 following LPS
stimulation (Cros et al., 2010; Rossol et al., 2012; Wong et al., 2011). Additionally, TNFα likely adds to the pro-inflammatory milieu. In response to LPS, TNF-α production has
been shown to both increase (Cros et al., 2010; Rossol et al., 2012) and remain unchanged
(Wong et al., 2011), which was suggested to be the result of different clones used to identify
CD14 (LPS receptor) (Wong et al., 2011). The use of the M5E2 clone for CD14 (as used
by Cros and colleagues (2010)) has demonstrated deleterious effects on the LPS signaling
(Power et al., 2004). However, with the elevated expression of CD14 on intermediate
monocytes, in conjunction with the positive LPS-mediated response (Cros et al., 2010), it
is unlikely the M5E2 clone had an impact on the results. Furthermore, Rossol and
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colleagues (2012) demonstrated similar TNF-α production following LPS stimulation,
though, the in vitro nature of these analyses may impact the findings (Wong et al., 2012).
Despite this, in response to LPS signaling it appears intermediate monocytes produce
multiple pro-inflammatory cytokines, likely leading to their pro-inflammatory nature.
The antigen presenting capabilities of intermediate monocytes appear to be related
to the increased expression of major histocompatibility (MHC) proteins human leukocyte
antigen (HLA)-ABC and HLA-DR relative to classical and nonclassical monocytes
(Rossol et al., 2012; Wong et al., 2011; Zawada et al., 2011). As these MHC molecules
function with T lymphocytes, they are capable of recruiting T cells to the injured area for
assistance in the healing process (Grage-Griebenow et al., 2001; Wong et al., 2012).
Therefore, modulation of the number of intermediate monocytes in circulation may
potentiate or mitigate the T cell response.

Nonclassical monocytes
Nonclassical monocytes are considered the most developed of the three monocyte
subsets (Wong et al., 2012; Ziegler-Heitbrock & Hofer, 2013). Nonclassical monocytes
make up approximately 5-10% of total monocytes, and are considered the “patrolling”
subset, residing primarily in the marginal pool (Cros et al., 2010). Other than the general
characteristic of CD14 and CD16, the nonclassical subset is phenotypically characterized
by a relatively high expression of CX3CR1, with relatively low expression of CCR2,
CCR5, CD11b and CD36 (Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011).
CX3CR1, the primary receptor for CX3CL1 (Ancuta et al., 2003), serves as the primary
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receptor involved in the extravasation process for nonclassical monocytes (Cros et al.,
2010; Yang et al., 2014).

In addition, due to the patrolling nature of nonclassical

monocytes, the phagocytic ability and ROS production of these monocytes have been
reported to be lower than the other monocyte subsets (Cros et al., 2010; Zawada et al.,
2011).
Cytokine production of nonclassical monocytes is rather controversial. In response
to LPS, Wong et al. (2011) reported elevated production of pro-inflammatory cytokines
(IL-1β, IL-6 and TNF-α). However, other investigations have demonstrated production of
only IL-1ra, with minimal production of pro-inflammatory cytokines (Cros et al., 2010;
Rossol et al., 2012). Additionally, as Cros and colleagues (2010) identified monocytes
with the M5E2 clone for CD14, the limited pro-inflammatory cytokine production
observed (Cros et al., 2010), may be a function of the deleterious effects of the M5E2 on
LPS signaling (Power et al., 2004). Unfortunately, the clone used by Rossol and colleagues
(2012), was not reported, and therefore may have the same limitations as reported by Cros
et al. (2010). However, Rossol and colleagues (2012) did report minimal pro-inflammatory
cytokine production following co-incubation with activated T-cells. Therefore, it is unclear
whether pro-inflammatory cytokine production is a prominent feature of nonclassical
monocytes.

Overview of the Monocyte Subsets
As stated previously, the relationship between the three monocyte subsets has been
suggested to be of a developmental nature, originating from classical monocytes (Ancuta
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et al., 2009; Ziegler-Heitbrock & Hofer, 2013).

This can be observed through the

progression of receptor expression and cytokine production between the subsets depicted
in Figure 3. Evidence demonstrating the modulation of key receptors on monocytes,
namely CX3CR1 and CD14 in response to specific cytokines has been presented
previously (Ramos et al., 2010). Specifically, Ramos and colleagues (2010) demonstrated
that IL-10 maintained the already elevated expression of CX3CR1 on cultured monocytes,
indicating a maintenance of the moderately matured state (intermediate monocyte).
Furthermore, when monocytes were cultured with INF-γ, CX3CR1 expression was also
maintained, however, a concomitant decrease in the expression of CD14 was demonstrated
(Ramos et al., 2010). This decrease in CD14 results in a phenotype characterized by low
CD14, but high CX3CR1 expression, similar to nonclassical monocytes (Wong et al.,
2012). Together, the results of Ramos and colleagues (2010) show a potential maturing
effect of the monocyte lineage under inflammatory conditions that present INF-γ.
In summary, the phagocytic classical monocytes express high levels of receptors
CCR2, CCR5, CD11b and CD62L, in conjunction with low expression of CX3CR1. As
classical monocytes mature into the inflammatory intermediate subset, they lose CD62L
expression, begin to lose the expression of CCR2, however, gain the expression of
CX3CR1 and HLA-DR. As these cells continue to develop into patrolling nonclassical
monocytes, the expression of CCR5, CD11b and HLA-DR is reduced, while the expression
of CX3CR1 is maintained (Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011). A
depiction of the differential expression of receptors and cytokine production is presented
in Figure 3.
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Figure 3: Phenotypic Differences of Monocyte Subsets.
Receptors and cytokines displayed in red, orange and white are highly, moderately
or minimally expressed/produced, respectively. Production of cytokines expressed
in grey are contested within literature.
Cytokines displayed: Monocyte chemoattractant protein-1 (MCP-1), Tumor
necrosis factor-α (TNF-α), and Interleukins (IL)- 1β, IL-6, IL-8 and IL-10.
Receptors displayed: Cluster of differentiation (CD)-14 (LPS receptor), CD16 (Fc
receptor FcγRIIIa), CD11b (α unit of MAC1), CD62L (L-selectin), CC chemokine
receptors 2 and 5 (CCR2, CCR5), CX3C chemokine receptor 1 (CX3CR1), and
Human Leukocyte Antigen (HLA)-DR

Macrophages
Macrophages are differentiated from monocytes within tissue following
transmigration (Yang et al., 2014). Similar to monocytes, macrophages are heterogeneous
and their functions are similarly varied (Novak & Koh, 2013; Pilling, Fan, Huang, Kaul, &
Gomer, 2009). Macrophages can be primarily separated into two categories, M1 and M2,
and the M2 macrophages can be further segregated into three subsets; M2a, M2b and M2c
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(Novak & Koh, 2013). These subsets, however, seem to be a function primarily of
controlled environments within in vitro analysis, and do not always maintain these ridged
phenotypes in vivo (Mosser & Edwards, 2008; Novak & Koh, 2013). The in vitro model,
however, may be helpful in understanding the myriad of roles macrophages participate in
during skeletal muscle damage and recovery.

Inflammatory (M1) Macrophages
Inflammatory macrophages (M1) are the first cells of the mononuclear phagocyte
system observed in skeletal muscle tissue following damage (Novak & Koh, 2013; Tidball
& Villalta, 2010). This typically occurs between 1 - 3 days following damage and is
preceded by neutrophil invasion, and characterized by a large inflammatory response
(Tidball, 2005; Tidball & Villalta, 2010). Furthermore, the macrophage response seems to
be required for complete skeletal muscle recovery following exercise induced muscle
damage (Cheng, Nguyen, Fantuzzi, & Koh, 2008; Rigamonti et al., 2013; Tidball &
Wehling-Henricks, 2007).
M1 macrophages originate from classical monocytes following migration to the
tissue, through a process known as classical activation (Yang et al., 2014). Classical
activation is primarily mediated by specific inflammatory cytokines, namely INF-γ,
although TNF-α has also been implicated in this process (Mosser & Edwards, 2008; Novak
& Koh, 2013). M1 macrophages are known to express CD68 (Pilling et al., 2009), a
receptor for oxidized low-density lipoprotein (oxLDL) (Tidball & Villalta, 2010; Van
Velzen, Da Silva, Gordon, & Van Berkel, 1997). CD68 will become more active with
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increased MPO-mediated oxidation of LDL (Zouaoui Boudjeltia et al., 2004), which is
released by neutrophils prior to M1 invasion (Kolaczkowska & Kubes, 2013). This leads
to the binding of CD68, contributing to the activation of the M1 macrophage (Tidball &
Villalta, 2010) and underlining the importance of the neutrophil response to muscle
damage. M1 macrophages appear to exclusively express CD80 (Ambarus et al., 2012),
however, do not express CD163 or CD206 (markers of M2 macrophages) (Novak & Koh,
2013).
Similar to neutrophils, M1 macrophages are known to contribute to secondary
damage, and is amplified in the presence of neutrophils (Nguyen & Tidball, 2003a). This
effect is facilitated via a nitric oxide- (NO) mediated reaction through the production of
inducible nitric oxide synthase (iNOS), further disrupting the integrity of the tissue
(Nguyen & Tidball, 2003a). Moreover, the secondary damage produced by iNOS appears
to be required for complete recovery (Rigamonti et al., 2013). M1 macrophages also aid
with the proliferation of myogenic precursor cells (MPC), and are the primary source of
intramuscular insulin-like growth factor-1 (IGF-1) during the early phase of recovery
(Arnold et al., 2007; Song et al., 2000; Tidball & Welc, 2015; Tonkin et al., 2015).
Additionally, M1 macrophages produce several pro-inflammatory cytokines, including IL1β, IL-6, IL-12, and TNF-α (Chazaud, 2014). Furthermore, T-helper 1 (Th1) lymphocytes
assist M1 macrophages by also secreting pro-inflammatory cytokines, including INF-γ
(Mosser & Edwards, 2008). The secretion of INF-γ from Th1 cells promotes classical
activation, and allows for the maintenance of M1 macrophages within the damaged tissue
(Mosser & Edwards, 2008).
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In conjunction with Th1 cells, M1 macrophages maintain this inflammatory milieu
throughout the early phase of recovery (Chazaud, 2014; Mosser & Edwards, 2008).
However, as classically activated macrophages begin to phagocytize debris, they begin to
polarize into a more anti-inflammatory phenotype (Arnold et al., 2007), a process that is
aided by the T-helper-2 lymphocyte (Th2) response (Chazaud, 2014). During this process,
the immune cells begin to promote a cytokine milieu consisting primarily of IL-4, and IL13, prompting “alternative” macrophage activation (Mosser & Edwards, 2008).

Anti-inflammatory (M2) Macrophages
Anti-inflammatory, or M2, macrophages are developed by phagocytosis or
alternative activation (Arnold et al., 2007; Mosser & Edwards, 2008). M2 macrophages
are the predominant cell of the mononuclear phagocytic system during the late phase of
inflammation, between 3 – 7 days following injury (Tidball & Villalta, 2010). The
polarization of M1 to M2 macrophages is typically mediated by phagocytosis or alternative
activation (Arnold et al., 2007). However, recent evidence from Tonkin and colleagues
(2015) suggests that the IGF-1 produced by M1 macrophages may contribute as well.
Development of M2 macrophages from nonclassical monocytes is mediated exclusively
through the alternative pathway (Brigitte et al., 2010; Nahrendorf et al., 2007).
Furthermore, the anti-inflammatory cytokines IL-4, IL-10 and IL-13 govern alternative
activation (Arnold et al., 2007). Prior to M2 development, nonclassical monocytes will
cross the endothelium via interaction of the CX3CR1 on the immune cell and CX3CL1,
which is bound to endothelial cells (Ancuta et al., 2003; Auffray et al., 2007).
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Due to the heterogeneity of the M2 subset, and the plasticity of macrophages in
general, it is difficult to identify a common receptor on all M2 phenotypes. Moreover,
macrophages are able to augment their phenotype and function based on the surrounding
environment (Mosser & Edwards, 2008; Novak & Koh, 2013; Stout et al., 2005). With
this in mind, macrophages that are cultured in cytokines characteristic of alternative
activation (IL-4 and IL-10) result in increased expression of CD163 and CD206 (Ambarus
et al., 2012; Buechler et al., 2000). M2 macrophages also promote an anti-inflammatory
milieu characterized by increased production of IL-1 receptor antagonist (IL-1ra), IL-10,
and transforming growth factor-β (TGF-β) (Ambarus et al., 2012; Chazaud, 2014; Song et
al., 2000; Stout et al., 2005). Furthermore, M2 macrophages display reduced expression
of pro-inflammatory cytokines TNF-α and IL-1β (Chazaud, 2014; Song et al., 2000; Stout
et al., 2005).
During the late phase of recovery, M2 macrophages promote the differentiation of
MPC into mature myotubes (Arnold et al., 2007; Martin & Lewis, 2012; Saclier et al.,
2013; Song et al., 2000). M2 macrophages also produce fibrous tissue (Song et al., 2000),
and continue to secrete IGF-1 within skeletal muscle (Tonkin et al., 2015). Due to the antiinflammatory environment promoted by M2 macrophages, IGF-1 is suggested to stimulate
the p70S6K signaling pathway (Tidball & Welc, 2015; Tonkin et al., 2015). Taken together,
M2 macrophages promote an anti-inflammatory environment that is characterized by
recovery and regeneration.
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Overview of M1/M2 Macrophages
Macrophages that respond to tissue damage are most readily defined by their
polarized moieties, M1 and M2. In general, these polarization states are characterized by
a pro-inflammatory M1 phenotype, that maintains an environment rich in the proinflammatory cytokines INF-γ and TNF-α (Chazaud, 2014).

The M2 phenotype is

characterized by the maintenance of an anti-inflammatory milieu, consisting of IL-4, IL10 and IL-13 (Gordon & Martinez, 2010). Furthermore, the M1 polarization contributes
to phagocytosis, and secondary damage (Tidball & Villalta, 2010), while also stimulating
MPC proliferation (Arnold et al., 2007; Song et al., 2000). The M2 polarization contributes
to fiber regeneration, and the promotion of MPC differentiation (Arnold et al., 2007;
Mosser & Edwards, 2008; Saclier et al., 2013). Additionally, M1 and M2 macrophages
provide the initial source of IGF-1 within skeletal muscle during recovery (Tonkin et al.,
2015). Many investigations have also suggested that macrophages exhibit great plasticity,
and caution against strict adherence to the M1/M2 characterization (Novak & Koh, 2013;
Stout et al., 2005).

Resident Macrophages
Resident macrophages were first identified in skeletal muscle in 1990 using specific
labeling with ectodermal dysplasia antibodies- 1, 2 and 3 (ED1, ED2 and ED3) (Honda,
Kimura, & Rostami, 1990). These antibodies labeled both monocytes and macrophages
(ED1), or were specific to macrophages (ED2 and ED3) (Dijkstra, Dopp, Joling, & Kraal,
1985). Honda and colleagues (1990) identified the presence of ED2 and ED3 macrophages
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within the perimysium (Honda et al., 1990), while a follow-up study by McLellan (1993)
determined that ED2 and ED3 macrophages did not participate in phagocytic activity
(McLennan, 1993). However, upon further examination it was determined that the animals
used by McLellan (1993) were likely not sacrificed in a resting state, indicating potential
for myeloid cellular invasion prior to analysis, and the results of this study should be
interpreted with caution. Subsequent examinations of the ED1, ED2 and ED3 phenotypes
have identified close relationships between these antibodies, and receptors currently used
to identify macrophages today, namely CD68, and CD163 (Damoiseaux et al., 1994;
Pilling et al., 2009; Polfliet, Fabriek, Daniels, Dijkstra, & van den Berg, 2006).
The findings of Honda and colleagues (1990) have subsequently been confirmed
with specific phenotyping for myeloid cells (MAC1/CR3), and mononuclear cells (F4/80)
(Pimorady-Esfahani, Grounds, & McMenamin, 1997). Recently, Brigitte and colleagues
(2010) demonstrated similar results with further discrimination against DC and classical
monocytes. Furthermore, they also demonstrated specific recruitment of monocytes and
neutrophils from resident macrophages. Briefly, following toxin (notexin) induced injury
to skeletal muscle, or stimulation with TNF-α, resident macrophages selectively produce
MCP-1 and cytokine-induced neutrophil chemoattractant (CXCL1) (Brigitte et al., 2010).
Additionally, patrolling monocytes (nonclassical) have been demonstrated to migrate into
tissue, and propagate the inflammatory response (Auffray et al., 2007). Consequently, both
resident macrophages and nonclassical monocytes appear to be involved with initiating the
immune response to tissue damage.
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Exercise itself, may also propagate the inflammatory response. Exercise is known
to induce increased mRNA expression of several chemokines in skeletal muscle, including
those for neutrophil and monocyte recruitment in humans (Catoire, Mensink, Kalkhoven,
Schrauwen, & Kersten, 2014; Della Gatta et al., 2014; Nieman et al., 2004; Stromberg et
al., 2016). While these investigations were unable to isolate the source of the mRNA
expression, it is possible myeloid cells were responsible. Evidence from a murine model
demonstrated myeloid depletion resulting in a significantly reduced mRNA expression of
pro-inflammatory cytokines (IL-6, TNF-α and IL-1β) post-exercise (Kawanishi,
Mizokami, Niihara, Yada, & Suzuki, 2016). Resident macrophages and monocytes appear
to produce these pro-inflammatory cytokines in the recovery period following exercise.
Consequently, these cells may be the primary cells responsible for the initiation of the
immune response to exercise induced muscle damage.

Endothelial Cells and Leukocyte Recruitment
While endothelial cells are not direct members of the innate immune system, they
do have a pivotal role in the development of the immune response (Ley et al., 2007).
Endothelial cells express specific adhesion receptors, namely P- and E-selectin
(Kolaczkowska & Kubes, 2013; Ley et al., 2007), which when activated will bind PSGL1, a prominent ligand of neutrophils (Futosi et al., 2013). Furthermore, once activated,
endothelial cells will also express CX3CL1, a chemoattractant to nonclassical monocytes
and T-cells (Ancuta et al., 2004; Ancuta et al., 2003; Ludwig, Berkhout, Moores, Groot, &
Chapman, 2002).

As these adhesion receptors and chemoattractants are expressed,
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immune cells will bind and initiate transendothelial migration. Activation of endothelial
cells is accomplished through various pro-inflammatory cytokines, such as TNF-α, INF-γ
and IL-1β (Ludwig et al., 2002; Rollins, Yoshimura, Leonard, & Pober, 1990). Moreover,
resistance exercise upregulates the production of IL-1β and TNF-α within skeletal muscle
(Buford, Cooke, & Willoughby, 2009; Nieman et al., 2004), likely sourced by resident
macrophages (Kawanishi et al., 2016).

Therefore, resistance exercise prompts the

production of pro-inflammatory cytokines that are responsible for the activation of
endothelial cells, indirectly contributing to the migration of leukocytes.

Immune Cell Response to Exercise-Induced Muscle Damage
It is well understood that resistance exercise may result in muscle damage resulting
from metabolic, oxidative stress, as well as mechanical stresses (Brancaccio, Lippi, &
Maffulli, 2010; Calle & Fernandez, 2010; Clarkson & Hubal, 2002; Clarkson, Kearns,
Rouzier, Rubin, & Thompson, 2006; Finaud, Lac, & Filaire, 2006). Myofibrillar damage
produced in skeletal muscle following damaging exercise is characterized by leakage of
various biomarkers from the sarcolemma (Brancaccio et al., 2010; Clarkson & Hubal,
2002; Clarkson et al., 2006), reduced voluntary contraction (Byrne & Eston, 2002; Paulsen
et al., 2005) and muscle soreness (Cheung, Hume, & Maxwell, 2003; Jajtner et al., 2015).
These indicators of exercise induced muscle damage are also associated with a proinflammatory cytokine response (Buford et al., 2009; Della Gatta et al., 2014; Nieman et
al., 2004), resulting in significant leukocyte mobilization (Paulsen et al., 2005; Ramel,
Wagner, & Elmadfa, 2003; Saxton et al., 2003; Simonson & Jackson, 2004). Resistance
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exercise appears to indirectly contribute to the recruitment of leukocytes by activating
resident tissue macrophages (Brigitte et al., 2010; Buford et al., 2009; Kawanishi et al.,
2016), which in turn, release potent chemoattractants and cytokines that stimulate
endothelial cell-mediated migration (Brigitte et al., 2010; Buford et al., 2009; Imai et al.,
1997; Kawanishi et al., 2016; Szmitko et al., 2003).
An overview of the immune cell cascade during recovery from skeletal muscle
damage is depicted in Figure 4. Briefly, resident macrophages and nonclassical monocytes
are activated, stimulating a response by endothelial cells, neutrophils and monocytes,
resulting in their infiltration of the damaged tissue (Brigitte et al., 2010; Kawanishi et al.,
2016; Ludwig et al., 2002; Rollins et al., 1990). Neutrophils are the first to arrive at the
site of damage, propagating inflammation, while also clearing debris (Kolaczkowska &
Kubes, 2013). Subsequently, classical monocytes infiltrate the tissue and develop into M1
macrophages, proliferating inflammation by essentially “priming” the tissue for recovery
(Tidball & Villalta, 2010). Simultaneously, Th1 cells are attracted to the site of damage,
possibly through antigen presentation performed by intermediate monocytes, and
contribute to the inflammatory milieu created during the early phase of recovery (GrageGriebenow et al., 2001; Wong et al., 2012). As M1 macrophages phagocytize debris within
the damaged tissue, polarization to an M2 phenotype occurs, establishing a
microenvironment more conducive to repair and healing (Arnold et al., 2007; Tidball &
Villalta, 2010). Concurrently, Th1 cells are replaced with Th2 cells, which support the
cytokine milieu associated with M2 macrophages during the late phase of skeletal muscle
recovery (Mosser & Edwards, 2008). Therefore, during the preliminary (neutrophil) and
early (M1 macrophage) phases of recovery, a pro-inflammatory microenvironment is
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supported, before yielding to an anti-inflammatory milieu during the late phase of recovery
(M2 macrophages) (Tidball & Villalta, 2010).

Figure 4: Overview of the Innate Immune Cells involved in Skeletal Muscle
Damage.
Resident macrophages and nonclassical monocytes induce a response to skeletal
muscle damage. Neutrophils are the first myeloid cell to enter the tissue (PMN
Infiltration). Within tissue, neutrophils promote phagocytosis, and release
myeloperoxidase (MPO), which contributes to secondary damage. Classical
monocytes enter the tissue and classically activate into M1 macrophages. M1
macrophages also contribute to secondary damage, as well as phagocytose
apoptotic neutrophils and debris prior to polarizing into M2 macrophages. M2
macrophages support the cessation of inflammation and the recovery of the tissue.
T-helper-1 (Th1) and -2 (Th2) cells aid with maintaining the pro- and antiinflammatory milieu, respectively.

Circulating Neutrophil Response to Exercise
It is well established that the number of neutrophils in circulation increase
following exercise (Miles et al., 1998; Nieman et al., 2004; J. M. Peake, K. Suzuki, G.
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Wilson, et al., 2005; Radom-Aizik, Zaldivar, Leu, Galassetti, & Cooper, 2008; Ramel,
Wagner, & Elmadfa, 2004).

Limited studies involving resistance exercise have

demonstrated an increase in neutrophil numbers immediately following exercise (Miles et
al., 1998; Nieman et al., 2004; Ramel et al., 2004; Simonson & Jackson, 2004).
Furthermore, elevations in neutrophil number are maintained for up to two hours postexercise (Nieman et al., 1995; Ramel et al., 2003). However, data regarding neutrophil
population 24 hours or more post-exercise in healthy participants appears to be lacking.
While examination of the neutrophil response to resistance exercise is limited,
examination of other modes of exercise may provide additional insight to the overall
neutrophil response. As resistance exercise may elicit muscle damage (Brancaccio et al.,
2010; Clarkson & Hubal, 2002), examination of the neutrophil response to exercise
designed to elicit muscle damage may provide evidence for a time course of neutrophil
recovery (Peake, Nosaka, & Suzuki, 2005).

Peak neutrophil counts resulting from

eccentrically induced muscle damage have been reported at 4- (Saxton et al., 2003), 6(Malm, Lenkei, & Sjodin, 1999; Malm et al., 2000; Paulsen et al., 2005), and 12-hours
(Pizza et al., 1996) post-exercise. Several investigators have further reported neutrophil
counts return to resting levels by 24-hrs following exercise induced muscle damage (Malm
et al., 1999; Paulsen et al., 2005; Saxton et al., 2003), while others, have reported a rebound
effect of total neutrophil count between 48H-96H post-exercise (Pizza et al., 1996). It has
also been suggested that the addition of muscle biopsies to an investigation may affect the
recruitment of neutrophils, and subsequently influence the rebound effect (Malm et al.,
2000). Based upon available evidence it appears that the neutrophil population will expand
for up to two hours following resistance exercise. However, if the intensity is sufficient to
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elicit muscle damage, this neutrophilia may continue for up to 12 hours before returning to
resting levels. While it is unclear whether a typical bout of resistance exercise will respond
in similar fashion to exercise designed to elicit muscle damage, there is evidence to support
a rebound effect 48 hours following muscle damage.

Circulating Monocyte and Monocyte Subset Response to Exercise
Total monocytes concentrations have been reported to increase in response to both
aerobic (Booth et al., 2010; Hong & Mills, 2008; Shantsila et al., 2012) and resistance
exercise (Miles et al., 1998; Nieman et al., 2004; Simonson & Jackson, 2004). Typically,
total monocyte count is elevated, peaking between immediately post-exercise and two
hours post-exercise (Ramel et al., 2003). It appears that both exercise intensity and rest
intervals may influence when this peak response occurs, with submaximal resistance
exercise prompting a delayed monocytosis (Mayhew, Thyfault, & Koch, 2005; Ramel et
al., 2003).
Investigations of monocyte subsets and their response to exercise have been
limited. This is likely due to the recent formal redefinition of monocytes to include a third
subset six years ago (Ziegler-Heitbrock et al., 2010). To our knowledge, following this
redefinition only seven investigations have been published discussing shifts in monocyte
subsets following exercise, with one additional investigation conducted in 2009 (Tables 1
and 2).

Briefly, these investigations primarily examined cardiorespiratory exercise

challenges, and typically assess the monocyte response only once, immediately following
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exercise. Additionally, some of these studies examined the changes of monocyte subsets
following exercise in clinical populations (Dimitrov et al., 2013; Dungey, Bishop, Young,
Burton, & Smith, 2015; Hong & Mills, 2008; Van Craenenbroeck et al., 2014) (see Table
2).
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Table 1. Monocyte Subset Modulations in response to Exercise in Healthy Populations.
Data reported as Mean (SD)
* Reported significant difference from pre; ~ no SD reported; Italics: Absolute Counts (109 x L-1).
Classical monocytes (CLAS), Intermediate monocytes (INTER), and nonclassical monocytes (NC)

Author

Participants
/ Exercise

Pre Exercise
CLAS INTER
NC

Post Exercise
CLAS
INTER

NC

1H Post Exercise
CLAS
INTER
NC

Simpson,
et al,
2009

"Mildly
Trained" Males
45 min Run at
75% VO2 Max

77.8 (7.4)

5.8 (2.5)

9.3 (3.5)

73.8 (9.4)*

7.1 (5.1)

12.4 (6.1)*

86.7 (7.3)*

3.6 (1.3)*

4.0 (1.7)*

Booth, et
al, 2010

Athletes (Men
and Women)
60km cycling
TT

86.8 (4.2)
0.38
(0.11)

5.1 (3.2)
0.02
(0.01)

11.2 (4.9)
0.05
(0.03)

77.3 (5.4)*
0.52
(0.14)*

9.7 (4.0)
0.06
(0.03)*

19.7 (4.8)*
0.14
(0.06)*

86.2 (10.1)
0.51
(0.18)

4.7 (5.5)
0.03
(0.05)

12.1 (9.7)
0.08
(0.08)

Shantsila,
et al,
2012

Healthy men
and women
Bruce Protocol

~ 85.2
~ 0.36

~ 2.1
~ 0.01

~ 12.6
~ 0.05

~ 85.1
~ 0.43

~ 2.9
~ 0.02

~ 12.0
~ 0.06

~ 85.1
~ 0.35

~ 2.9
~ 0.01

~ 12
~ 0.05

RadomAizik, et
al, 2014

Healthy Young
Men
10 x 2min
(1min Rest)
~82% of max
Cycle
Ergometer

Absolute % and Counts Unreported
(Depicted in a Figure)

Decreased
Increased

Unchanged
Unchanged

Increased
Increased

N/A

N/A

N/A

LaVoy,
et al,
2015

Healthy Men
and Women
Bruce Protocol

65.7 (7.7)

53.0 (8.6)*

15.9 (6.7)*

14.1 (6.3)*

N/A

N/A

N/A

7.6 (2.9)

6.8 (3.9)
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Table 2. Monocyte Subset Modulations in response to Exercise in Clinical Populations.
Data reported as Mean (SD)
* Reported significant difference from pre; ~ no SD reported
Classical monocytes (CLAS), Intermediate monocytes (INTER), and nonclassical monocytes (NC)

Author
Dimitrov, et al,
2013

Van
Craenenbroeck,
et al, 2010

Dungey, et al,
2015

Participants /
Exercise
Men and Women
with Normal and
Pre-hypertension
Bruce Protocol
Chronic Kidney
and Heart Disease
Patients; Healthy
Sedentary
Cycling VO2 Max;
10-20W/min
Hemodialysis
Patients
30 min Cycle at
"somewhat hard"
intensity during
hemodialysis

CLAS

Pre Exercise
INTER

CLAS

Post Exercise
INTER

NC

NC

~ 87.9

~ 4.8

~ 4.2

~ 86.7*

~ 5.0

~ 5.0*

HS: 88.1 (4.7)
CKD: 88.5 (4.3)
CHF: 87.4 (3.5)

HS: 4.5 (2.1)
CKD: 3.6 (1.7)
CHF: 4.7 (2.5)

HS: 7.4 (3.2)
CKD: 8.0 (3.6)
CHF: 7.9 (2.2)

HS: 83.1 (6.0)
CKD: 85.3 (3.7)
CHF: 85.9 (4.3)

HS: 5.6 (2.3)
CKD: 4.4 (1.6)
CHF: 4.8 (2.2)

HS: 11.3 (4.6)
CKD: 10.3 (3.0)
CHF: 9.4 (3.1)

82.2 (5.3)

7.5 (2.4)

10.3 (3.9)

83.9 (4.3)

5.5 (1.9)

10.6 (3.9)
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Prior to the redefinition, investigations demonstrated selective expansion of CD16+
monocytes following exercise, the magnitude of which was dependent on the intensity of
exercise (Steppich et al., 2000). Furthermore, the increase in nonclassical monocytes
following exercise may be related to a mobilization from the marginal pool stimulated by
the catecholamine response to exercise (Fragala et al., 2011; Kittner et al., 2002). This
seems to be consistent even in patients with elevated blood pressure (Hong & Mills, 2008).
Despite this, the previous studies demonstrated their results without the incorporation of
the intermediate monocyte population. With the new nomenclature, the response of the
intermediate subset must be isolated from the nonclassical population, and defined more
thoroughly.
While the overall count of all monocyte subsets have been demonstrated to increase
with exercise (Booth et al., 2010; Radom-Aizik et al., 2014; Shantsila et al., 2012), the
proportion of each subtype in relation to the total population of monocytes may be variable.
Immediately following aerobic exercise, a significant decrease in the proportion of
classical monocytes is generally observed (Booth et al., 2010; LaVoy et al., 2015; RadomAizik et al., 2014; Shantsila et al., 2012; Simpson et al., 2009). This decrease is often
associated with increases in the proportion of nonclassical only (Booth et al., 2010;
Dimitrov et al., 2013; Radom-Aizik et al., 2014; Simpson et al., 2009), while others report
a significant increase in the proportion of both intermediate and nonclassical monocytes
(LaVoy et al., 2015). The difference observed between the former and latter investigations
may be related to differences in the gender of the participant populations. LaVoy and
colleagues (2015), utilized a mixed gender group of participants.

The nonclassical

monocyte population appears to respond differently to exercise in women than men
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(Heimbeck et al., 2010), which suggests that the use of a mixed gender population may
result in a different or varied response. Currently, to the best of our knowledge, there does
not appear to be any data available regarding the monocyte subset response to resistance
exercise.
Only two studies appear to have examined the response of monocyte subsets one
hour post-aerobic exercise, and the response was unclear.

Initially, Simpson and

colleagues (2009) reported a significant increase in the proportion of classical monocytes,
and a decrease in the proportion of both intermediate and nonclassical subsets one hour
following endurance exercise. Subsequently, Booth and colleagues (2010) reported no
differences in the monocyte subset proportions one hour post-exercise. These differences
may have been related to differences in either the exercise modality used or the training
status of the participants. Briefly, “moderately trained” participants completed 45 minutes
of running (Simpson et al., 2009), compared to “athletes” completing a 60km cycling time
trial (Booth et al., 2010). Considering that running produces greater muscle damage,
especially in moderately trained individuals, than cycling (Millet & Lepers, 2004), it stands
to reason that a greater extent of muscle damage may have contributed to the greater
response observed with running.
Due to the absence of examinations involving skeletal muscle damage in humans,
and the heterogeneity that exists between the murine and human models of monocyte
subsets, it is unclear whether the intermediate subset responds to tissue damage. Evidence
from the ischemic model of tissue injury indicates a potential link between tissue damage
and mobilization of the intermediate subset (Tapp et al., 2012; Zhu et al., 2015). Following
acute ischemic injury, patients have demonstrated an elevated proportion of intermediate
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from 1-7 days following an acute myocardial infarction (Tapp et al., 2012), and two days
following a stroke (Urra et al., 2009). Although speculative, these data suggest a potential
relationship between the proportion of intermediate monocytes and tissue damage.

Chemokine Response to Exercise
As stated previously, cytokines function as messengers between cells (Nicod,
1993). Chemokines form a family of cytokines that function primarily as chemoattractants
for immune cells (Rollins, 1997). While chemokines typically recruit specific immune cells
to the site of tissue damage, several other cytokines elicit specific responses from immune
cells (Calle & Fernandez, 2010; Pedersen, Akerstrom, Nielsen, & Fischer, 2007). As the
immune cells respond to signals from cytokines and chemokines, a pro- or antiinflammatory environment is formed, leading to the classification of cytokines as pro- or
anti-inflammatory (Calle & Fernandez, 2010). While several cytokines and chemokines
are active during recovery from muscle damage, for the purpose of this review, we will
focus on the chemokines known to recruit specific immune cells, including interleukin-8
(IL-8), monocyte chemoattractant protein-1 (MCP-1), and fractalkine (CX3CL1).

Interleukin-8 (IL-8)
Interleukin 8 (IL-8) is a CXC chemokine (CXCL8) that has been suggested to
perform two primary functions; neutrophil activation and angiogenesis (Pedersen et al.,
2007; Rollins, 1997). IL-8 is known to interact with two CXC chemokine receptors
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(CXCR1 and CXCR2) (Pedersen et al., 2007; Schraufstatter, Chung, & Burger, 2001), and
is produced by a variety of cells/tissues, including monocytes (Cros et al., 2010; Wong et
al., 2011), as well as adipose and muscle tissue (Bruun et al., 2004; Chan, Carey, Watt, &
Febbraio, 2004; Nieman et al., 2003). Despite the multitude of production locations, it is
likely that IL-8 produced by adipose tissue contributes little to the activation of neutrophils
(Ribeiro et al., 1991). Therefore, the chemotactic properties of IL-8 on neutrophils are
likely due to production from the myeloid cellular lineage or skeletal muscle.
Production of IL-8 within skeletal muscle has been demonstrated following both
aerobic (Chan et al., 2004; Nieman et al., 2003) and resistance exercise (Chan et al., 2004;
Nieman et al., 2004). Although not directly compared (analyses were completed by the
same research group), the change in mRNA expression of IL-8 from pre to post exercise
appears to be lower following high volume resistance exercise when compared to high
volume running (Nieman et al., 2004; Nieman et al., 2003). Della Gatta and colleagues
(2014) also demonstrated an increased mRNA expression of IL-8 following resistance
exercise, which corresponded to an increased concentration of IL-8 within skeletal muscle.
However, whether this increase in skeletal muscle IL-8 concentration is translatable to IL8 in circulation is uncertain.
Increases in circulating IL-8 have been reported following exercise consisting of
both concentric and eccentric muscle actions (Pedersen et al., 2007). Therefore, it is not
surprising to find significant increases in circulating IL-8 following running exercise
(Nieman et al., 2003), but not after concentrically based exercises, such as cycling and
rowing (Chan et al., 2004; Henson et al., 2000). It stands to reason that with the response
of neutrophils to tissue damage (Tidball, 2005), and the chemotactic properties of IL-8 on
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neutrophils (Ribeiro et al., 1991; Rollins, 1997) that skeletal muscle damage may be a
requisite stimulus for increases in IL-8 concentrations in circulation.
Resistance exercise though has not demonstrated the expected results in regard to
circulating IL-8. Most investigations that have examined circulating IL-8 following
resistance exercise, or exercise designed to elicit muscle damage, have reported no change
(Buford et al., 2009; Paulsen et al., 2005; Ross et al., 2010), while one investigation
demonstrated a decrease in response to exercise (Hirose et al., 2004). However, increased
circulating IL-8, in conjunction with increased mRNA expression of IL-8 in skeletal
muscle, has been reported following high volume resistance exercise (Nieman et al., 2004).
A plausible explanation for the different results observed could be related to the total
volume of exercise completed.
To our knowledge, only one study has demonstrated a significant increase in
circulating IL-8 concentrations following resistance exercise.

This study required

participants to perform 4 sets of 10 repetitions of 10 different multi-joint, whole body
exercises. The first set was performed at 40% of the one-repetition maximum (1RM) and
60% 1RM for sets 2-4 (Nieman et al., 2004). In contrast, no changes in IL-8 concentrations
were noted following one investigation requiring participant to perform 300 forced
eccentric repetitions of the knee extensor exercise (Paulsen et al., 2005), or 50 eccentric
contractions of the leg press exercise (Ross et al., 2010). Furthermore, Buford and
colleagues (2009) utilized a dynamic resistance exercise bout requiring 3x10 repetitions of
the squat, leg press and leg extension exercises. Although no change in circulation IL-8
concentrations were reported, they did observe a significant increase in the mRNA
expression of IL-8 (Buford et al., 2009). Interestingly, Hirose et al (2004) demonstrated a
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decrease in IL-8 concentrations following forced eccentric exercise of the elbow flexors (4
x 5 repetitions), which consequently was the lowest volume of all the studies
examined(Hirose et al., 2004). Thus, each investigation that reported no change or
decreased concentrations of IL-8 incorporated significantly less volume of exercise than
Nieman and colleagues (2004). Therefore, IL-8 concentrations may only increase in
circulation following exercise of sufficient volume, however, further investigation appears
needed.

Monocyte Chemoattractant Protein -1 (MCP-1/CCL2)
Monocyte chemoattractant protein-1 (MCP-1) is a member of the CC subfamily of
chemokines, and is also referred to as CCL2 (Yadav et al., 2010). Of the many proposed
functions of MCP-1, monocyte chemoattraction appears to be its primary responsibility,
principally for classical monocytes (Wong et al., 2012; Yadav et al., 2010; Yang et al.,
2014). Furthermore, the primary receptor responsible for ligation of MCP-1 is the CC
chemokine receptor CCR2 (Rot & von Andrian, 2004; Yadav et al., 2010). Production of
MCP-1 occurs in the endothelial cells, classical monocytes, and within skeletal muscle
tissue (Cros et al., 2010; Cushing et al., 1990; Della Gatta et al., 2014; Wong et al., 2011).
With the pivotal role of classical monocytes during recovery from resistance exercise, the
investigation of MCP-1 in response to resistance exercise is warranted. Despite this, the
examination of MCP-1 in circulation following resistance exercise is rather limited.
To our knowledge, only two investigations have examined the effects of dynamic
resistance exercise on circulating MCP-1 concentrations.
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A previous investigation

demonstrated elevated mRNA expression of MCP-1 within skeletal muscle following
resistance exercise, which also translated into an increased expression of MCP-1 within the
skeletal muscle tissue for up to four hours (Della Gatta et al., 2014). However, this study
did not examine circulating changes in MCP-1 concentrations (Della Gatta et al., 2014).
In another investigation, Ihalainen and colleagues (2014) demonstrated no change in MCP1 concentrations following two different exercise bouts (15 x 1-RM or 5 x 10 repetitions
at 80% 1-RM) immediately, or 15-min post-exercise. However, a significant decrease in
MCP-1 concentrations were observed 30 minutes post-exercise. Conversely, Wells and
colleagues (2016) reported a significant, immediate increase of circulating MCP-1 in
response to both a high volume and a high intensity bout of resistance exercise for at least
5-hours post-exercise. A reasonable explanation for the discrepancy in these reports is the
level of muscle damage that was elicited. Ihalainen et al. (2014) observed 2-fold increase
in myoglobin concentrations, versus the 5-8 fold increase observed by Wells and
colleagues (2016). Thus, the extent or magnitude of skeletal muscle damage may provide
further insight to the cause of increased MCP-1 concentration.
Previous work investigating exercise designed to elicit muscle damage (e.g.
downhill running, etc.,) has indicated a significant increase in circulating MCP-1
immediately following exercise (Crystal, Townson, Cook, & LaRoche, 2013; Paulsen et
al., 2005; J. M. Peake, K. Suzuki, M. Hordern, et al., 2005). These responses appear to be
maintained for at least six hours following damage before returning to resting levels by 24
hours post-exercise (Crystal et al., 2013; Paulsen et al., 2005). Crystal and colleagues
(2013) also demonstrated a biphasic response of MCP-1, with initial increases immediately
following exercise, and a subsequent increase at 6H that may be attenuated with cold water
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immersion (Crystal et al., 2013).

Peake and colleagues (2005) also demonstrated

significant increases in MCP-1 concentrations at 1-hr post-exercise. Greater increases,
however, were observed following high intensity running (85% of VO2max for 60 min)
than after downhill running (-10% gradient; 60% VO2max for 45 min) (J. M. Peake, K.
Suzuki, M. Hordern, et al., 2005).
It is unclear whether the volume of exercise, or the level of muscle damage
regulates circulating MCP-1 concentration. Wells and colleagues (2016) suggested that
volume of exercise may explain the different results obtained in the investigations utilizing
dynamic resistance exercise. Considering that both of these investigations reported no
differences between high and low volume exercise (Ihalainen et al., 2014; Wells et al.,
2016), we argue that muscle damage may be a more likely explanation. Nonetheless,
further research is warranted to determine the impact of muscle damage or the volume of
exercise on MCP-1 concentrations.

Fractalkine (CX3CL1)
Fractalkine is the sole member of the CX3C chemokine family (CX3CL1), and is
the primary chemokine responsible for the recruitment and activation of nonclassical
monocytes (Bazan et al., 1997), and Th cells (Foussat et al., 2000). Additionally, CX3CL1
will ligate with the CX3C chemokine receptor CX3CR1 (Ancuta et al., 2003), which is
prominent on both intermediate and nonclassical monocytes (Cros et al., 2010; Wong et
al., 2011). CX3CL1 is produced by endothelial cells under inflammatory conditions,
namely through interaction with TNF-α and INFγ (Ludwig et al., 2002) as well as within
skeletal muscle tissue following exercise (Catoire et al., 2014; Della Gatta et al., 2014;
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Stromberg et al., 2016). CX3CL1 produced in endothelial cells, however, is bound to the
endothelial membrane, and serves as an adhesion molecule during transmigration of
monocytes and lymphocytes to sites of damage (Ancuta et al., 2003; Fong et al., 1998; Imai
et al., 1997). Soluble CX3CL1 (sCX3CL1) is released into circulation, when it is cleaved
from the endothelial cell, and will promote chemotaxis of monocytes and Th cells alike
(Ancuta et al., 2003; Foussat et al., 2000). The cleaving of CX3CL1 occurs in the presence
of pro-inflammatory cues, such as TNF-α and IL-1β (Turner, Mangnall, Bird, Blair-Zajdel,
& Bunning, 2010). As a result, elevations of sCX3CL1 can be expected in circulation
during inflammatory conditions that increase both TNF-α and IL-1β.
Prior to 2014, no investigations examined the impact of exercise on CX3CL1 or
sCX3CL1. Since then, three investigations have been published demonstrating increased
skeletal muscle mRNA expression of CX3CL1 (Della Gatta et al., 2014), as well as
increased CX3CL1 within skeletal muscle (Stromberg et al., 2016) and plasma (Catoire et
al., 2014). Catorie and colleagues (2014) observed a significant increase in mRNA
expression of CX3CL1 following one hour of unilateral cycling (at 50% of their unilateral
VO2 max). The increase in mRNA expression translated to a significant increase in
circulating sCX3CL1 immediately, and 2-hrs post-exercise (Catoire et al., 2014).
Following resistance exercise, Della Gatta and colleagues (2014) demonstrated significant
increases in mRNA expression of CX3CL1 at 2-hrs, but not 4-hrs, post exercise. Recently,
Stromberg et al. (2016) observed significant increases in CX3CL1 mRNA expression 30
minutes following bilateral cycling (Workload: 50% of VO2 max for one hour), and a
subsequent return to baseline at 2-hrs post-exercise. The mRNA expression of CX3CL1
paralleled an increase in CX3CL1 protein content observed within skeletal muscle
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(Stromberg et al., 2016). However, it is unclear if the CX3CL1 observed within the skeletal
muscle was bound to endothelial cells or whether it was soluble.
Evidence is clear that both aerobic and resistance exercise will increase mRNA
expression of CX3CL1, however, the time course of sCX3CL1 and CX3CL1 mRNA
expression appears to be quite variable. It appears that elevations in mRNA expression of
CX3CL1 is delayed following resistance exercise compared to aerobic exercise (Della
Gatta et al., 2014; Stromberg et al., 2016). However, Della Gatta and colleagues (2014)
did not assess mRNA expression of CX3CL1 prior to 2-hr post-exercise. Consequently,
whether the increase in mRNA expression of CX3CL1 observed at 2-hr post-exercise is a
sustained or a delayed response remains unclear (Della Gatta et al., 2014). Furthermore,
the suggestion that increases in mRNA expression within skeletal muscle prompts
sCX3CL1 increases in circulation (Catoire et al., 2014), has yet to be definitively
demonstrated following resistance exercise. Therefore, further investigation is required to
elucidate the time course of CX3CL1 and sCX3CL1 following resistance exercise.

The αMβ2 Integrin, MAC1/CR3 (CD11b/CD18)
Macrophage-1 antigen (MAC1) or complement receptor 3 (CR3) is a heterodimeric
integrin that consists of two subunits, αM (CD11b) and the common β2 subunit (CD18)
(Ehlers, 2000). As one of the most studied integrins, the vast array of functions associated
with MAC1/CR3 range from a potent phagocytic stimulator (Tan, 2012) to providing a
pivotal role in immune cell migration (Ley et al., 2007). Furthermore, MAC1/CR3 can be
activated by several methods, including ligation with P-selectin glycoprotein ligand-1
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(PSGL1) (Evangelista et al., 1999), or activation through inflammatory cytokines, like
TNFα (Montecucco et al., 2008). Despite the vast, and varied roles of MAC1/CR3, the
greatest impact on overall immune function appears to be its role in endothelial migration.
As immune cells are attracted to the site of damaged tissue through an intricate
signaling network of chemokines (Freidenreich & Volek, 2012; Rollins, 1997), they
encounter the endothelial wall, which acts as the final barrier to the damaged tissue
(Gerhardt & Ley, 2015). Immune cells will systematically employ specific adhesion
molecules that mediate the transendothelial migration to the tissue, a process referred to as
the leukocyte adhesion cascade (Ley et al., 2007). Furthermore, molecules within the
leucocyte adhesion cascade can be divided into two primary sub-categories, selectins and
integrins, while the cascade itself can be divided into five major processes: tethering,
rolling, adhesion, crawling and extravasation (Gerhardt & Ley, 2015).
During the leukocyte adhesion cascade, selectins primarily function during the
early phases (tethering and rolling), while the integrins function primarily in the later
phases (adhesion, crawling and extravasation) (Kolaczkowska & Kubes, 2013). Briefly,
the adhesion cascade is initiated by the ligation of PSGL-1 to its receptors on the
endothelial wall, P-selectin, and later E-selectin (Evangelista et al., 1999; Kansas, 1996).
Following the initial tethering, P- and E-selectin as well as PSGL-1 on the leukocyte
continue the rolling process, gradually progressing to a slow rolling state with increasing
contribution from L-selectin (CD62L) (Ley et al., 2007). As the rolling phase continues to
slow, integrins become more involved, until adhesion can occur. Adhesion is mediated by
the cell adhesion molecules intracellular adhesion molecule-1 (ICAM1) and vascular cell
adhesion molecule-1 (VCAM1) located on the endothelial surface, and the integrin
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lymphocyte function-associated antigen-1 (LFA-1) located on the immune cell (Tan,
2012). Crawling, which is mediated by the interaction of ICAM1 with MAC1/CR3, is
initiated once the cells are firmly adhered to the vessel wall. It requires slight movement
to position the leukocyte over the endothelial junction to allow for transmigration into the
damaged tissue through a paracellular route (Ley et al., 2007).

While transcellular

migration across the endothelium is possible, evidence suggests immune cells
preferentially migrate by paracellular means (Gerhardt & Ley, 2015).

Furthermore,

MAC1/CR3 aides in the paracellular migration of immune cells by interacting with
junctional adhesion molecules near the endothelial junctions (Gerhardt & Ley, 2015).
While each process is required for complete migration to the location of damage, the
specific modulation of MAC1/CR3 has also been demonstrated to modify immune cell
infiltration.
Increased expression of MAC1/CR3 on monocytes has been implicated in
increased adherence to the endothelial wall (Weber, Erl, & Weber, 1995). Likewise,
decreased expression of MAC1/CR3 leads to decreased adhesion to the endothelial wall
(Arakawa et al., 2010). Similarly, mice that are injected with anti-CD11b toxin display
limited infiltration into damaged tissue (Rosen & Gordon, 1987). Direct activation of
MAC1/CR3 on neutrophils is mediated through the pro-inflammatory cytokine TNF-α
(Montecucco et al., 2008). Recent evidence suggests a relationship between MAC1/CR3
expression on monocytes and MCP-1 (Wells et al., 2016). Evidence appears to indicate a
significant impact of MAC1/CR3 in the overall recovery of skeletal muscle from exercise
stress.
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MAC1/CR3 Responses to Exercise Stress
An efficient transmigration of cells into the damaged tissue is paramount to optimal
recovery, underlining the importance of MAC1/CR3 in the recovery process. While
MAC1/CR3 has been examined frequently, there is still little consensus on the overall
response and time course of MAC1/CR3 expression on leukocytes following exercise.
This is likely due to the vast array of exercise protocols that have been examined (Gavrieli
et al., 2008; Jordan et al., 1999).

Neutrophil Expression of MAC1/CR3 following Exercise
Aerobic exercise has often been used to examine the expression of CD11b in
response to exercise. No change in CD11b expression on neutrophils were reported by two
investigations in response to moderate duration and intensity exercise (30 min at 75% VO2
max or 60 min at 60% VO2 max) (Gavrieli et al., 2008; Kurokawa, Shinkai, Torii, Hino, &
Shek, 1995). Similarly, Jordan and colleagues (1999) demonstrated no significant change
in CD11b expression following moderate intensity (50-60%) running for three hours.
However, during prolonged endurance events (i.e. a marathon) CD11b expression was
demonstrated to both increase (Jordan et al., 1999) and remain at pre-exercise levels
(Nielsen & Lyberg, 2004).

While these results are conflicting, differences in

environmental stresses and hydration status may have influenced these results (Jordan et
al., 1999).
As exercise intensity increases, there appears to be greater consistency of the
MAC1/CR3 response on neutrophils. Graded exercise tests have been a common mode of
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exercise to examine the neutrophil expression of MAC1/CR3 at maximal effort. Studies
using this exercise model consistently demonstrate significant increase in CD11b
expression immediately following exercise (Jordan et al., 1999; van Eeden et al., 1999).
Increases in the expression of CD11b following graded exercise was reported within
minutes of the initial exercise stimulus, and remained elevated for at least 30 minutes postexercise (van Eeden et al., 1999).

Furthermore, Gabriel and Kindermann (1998)

demonstrated an increase in the expression of CD11b immediately following an intense
(110% of anaerobic threshold for approximately 20 minutes) bout of cycling exercise, with
a subsequent decrease in expression two hours into recovery.
Exercise designed to elicit muscle damage has also been used to examine
MAC1/CR3 expression on granulocytes, producing equivocal results (J. M. Peake, K.
Suzuki, G. Wilson, et al., 2005; Pizza et al., 1996; Saxton et al., 2003). Pizza and
colleagues (1996) initially examined the effects of forced eccentric elbow flexion on
granulocyte CD11b expression. Interestingly, increases were observed only between 24
and 96 hours following exercise (Pizza et al., 1996), long past the expected time course of
neutrophil activation (Kolaczkowska & Kubes, 2013). Others observed no changes in
neutrophil expression of CD11b following exercise induced muscle damage (J. M. Peake,
K. Suzuki, G. Wilson, et al., 2005; Saxton et al., 2003), but they used direct isolation
methods to identify granulocytes.
Expression of MAC1/CR3 on granulocytes appears to be modulated primarily by
exercise intensity, particularly as a function of VO2 max (Gabriel & Kindermann, 1998;
van Eeden et al., 1999). Of the investigations presented, significant increases were most
consistently observed when near maximal effort was used (Gabriel & Kindermann, 1998;
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van Eeden et al., 1999). Consequently, it seems that exercise induced muscle damage may
not affect neutrophil expression of MAC1/CR3.

However, to our knowledge, no

investigations have examined neutrophil expression of MAC1/CR3 in response to a
dynamic resistance exercise bout, demonstrating the need for further investigation in the
area of resistance exercise.

Monocyte Expression of MAC1/CR3 following Exercise
Similar to the MAC1/CR3 expression on neutrophils, the characterization of the
MAC1/CR3 response to exercise on monocytes has been ambiguous. Increases in CD11b
expression have been previously demonstrated following both a marathon and halfmarathon (Nielsen & Lyberg, 2004). Furthermore, the use of dynamic body weight
exercises (5 sets of 30 lunge exercises) have also demonstrated significant elevations in
CD11b expression on monocytes during recovery (Malm et al., 1999). However, studies
using exercise modalities that induce acute muscle damage have yielded inconsistent
results. In a study on recreationally active men no change in CD11b expression on
monocytes was reported following 50 eccentric contractions of the knee extensors (Saxton
et al., 2003). In contrast, Pizza and colleagues (1996) demonstrated significant elevations
in CD11b expression 24 hours following 25 eccentric contractions of the elbow flexors in
untrained individuals. It is likely that training experience of the participants contributed to
these differences. Still, the exercise stimuli employed by both studies were isolated
movements, and may not be translatable to dynamic resistance exercise.
Following dynamic resistance exercise the expression of CD11b on monocytes has
been reported to increase 30-min following exercise, and return to resting levels at 24- and
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48-hrs post exercise (Gonzalez et al., 2014; Jajtner et al., 2014). Recently, Wells and
colleagues (2016) demonstrated a significant increase in CD11b expression on monocytes
immediately, and 1-hr post-exercise. The immediate increase contrasts with the findings
of Jajtner et al. (2014) and Gonzalez, et al. (2014), who demonstrated no significant
increase immediately following exercise.

While each study utilized experienced,

resistance-trained participants performing an acute bout of resistance exercise, the
differences could be attributable to the identification of monocytes in each study. Gonzalez
et al. (2014) and Jajtner et al. (2014) identified monocytes with CD14 exclusively
(CD14++). In contrast, Wells and colleagues (2016) utilized CD14 in conjunction with
CD16 to identify classical monocytes (CD14++/CD16-). As intermediate and classical
monocytes express CD14 at similar levels (Wong et al., 2012), it is likely the CD14++
monocytes analyzed by Gonzalez et al (2014) and Jajtner et al (2014) incorporated both
classical and intermediate monocytes. Furthermore, classical and intermediate monocytes
are both known to express CD11b (Wong et al., 2012). While speculative, the inclusion of
intermediate monocytes may have influenced the expression of CD11b on the CD14++
monocytes reported by Gonzalez et al. (2014) and Jajtner et al. (2014). However, to our
knowledge, no investigation has examined the CD11b response on intermediate
monocytes.

Therefore, future research examining the impact of dynamic resistance

exercise on the expression of CD11b on the different monocyte subsets is needed.
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Polyphenol Supplementation
Polyphenols are micronutrients that are the most plentiful antioxidant in the diet,
and are common in many plant-based foods and beverages, such as fruits, tea and coffee
(Manach, Scalbert, Morand, Remesy, & Jimenez, 2004; Scalbert, Johnson, & Saltmarsh,
2005). Polyphenols are characterized by their structure, which contains multiple hydroxyl
groups on aromatic rings (Manach et al., 2004). Based on their structure, polyphenols are
broken into four main classifications, phenolic acids, flavonoids, stilbenes, and lignans
(Manach et al., 2004). Flavonoids can be further classified into six distinct classifications,
and appear to be the most common polyphenol supplement examined with exercise
(Manach et al., 2004; Myburgh, 2014).
Human cells continually produced reactive oxygen species (ROS), a process that is
intensified during exercise (Merry & Ristow, 2015; Urso & Clarkson, 2003).

As

polyphenols are known antioxidants, their use during and following exercise has been the
subject of recent investigation (Bowtell et al., 2011; Jowko et al., 2011; Panza et al., 2008).
Acute polyphenol supplementation has been demonstrated to reduce strength deficits
following exercise that elicits muscle damage (Herrlinger et al., 2015; Machin et al., 2014),
as well as resistance exercise (Bowtell et al., 2011; Jowko et al., 2011; Panza et al., 2008).
Data regarding polyphenol supplementation and the immune response to exercise,
however, is limited.
Most investigations that have examined polyphenol supplementation and the
exercise response have employed a high volume aerobic exercise model. Nieman and
colleagues (2013) assessed changes in cytokine concentration following three days of high
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volume running (2.5-hr at 65% VO2max) with or without polyphenol supplementation.
While all measured cytokines (IL-6, IL-8, IL-10, MCP-1, G-CSF and TNF-α) increased
due to exercise, no differences were observed in response to polyphenol supplementation
(Nieman et al., 2013). Similarly, no differences in plasma cytokine concentration (IL-1ra,
IL-6, IL-8, IL-10, MCP-1, G-CSF or TNF-α) were reported following a 163km running
race between placebo or quercetin supplementation (Nieman, Henson, Davis, et al., 2007).
Cycling at ~57% on of VO2max for 3-hr on three consecutive days also demonstrated no
differences in immune cell populations between quercetin and placebo groups (Nieman,
Henson, Gross, et al., 2007). Additionally, polyphenol supplementation resulted in no
differences following downhill running or repeated sprints on a cycle ergometer for TNFα, IL-1β and IL-6, or IL-6 alone, respectively (Arent, Senso, Golem, & McKeever, 2010;
Herrlinger et al., 2015). Similarly, Kerksick and colleagues (2010) showed no differences
in TNF-α concentration following 100 eccentric contractions of the leg extensors in
conjunction with EGCG supplementation. However, a significant decrease in the number
of neutrophils were observed 24-72 hours following exercise with ECGC supplementation
for 14 days (Kerksick et al., 2010). Although polyphenol supplementation does not
influence the cytokine response to exercise, evidence does suggest that EGCG
supplementation can suppress the neutrophil response to eccentric exercise eliciting muscle
damage. Nevertheless, no changes in the granulocyte population have been reported
following quercetin supplementation and high volume exercise.
Polyphenols, appear to elicit their effects within the context of immune cell
adhesion. Evidence from in vitro modeling have demonstrated significant downregulation
of CD11b on the surface of both monocytes and neutrophils, as well as limited chemotaxis
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(Graff & Jutila, 2007; Kawai et al., 2004; Takano et al., 2004). Evidence of reduced CD11b
expression on monocytes in response to polyphenol supplementation has also been
presented in clinical populations (Chiva-Blanch et al., 2012). However, there does not
appear to be any investigations conducted examining the response of CD11b expression to
exercise in conjunction with polyphenol supplementation.

Conclusions
Previous investigations of the immune response to exercise and exercise induced
muscle damage have elucidated many distinct functions of myeloid and non-myeloid cells
during recovery. Following tissue injury, patrolling nonclassical monocytes and resident
macrophages initiate the release of specific cytokines and chemokines. These in turn
activate endothelial cells, and stimulate the recruitment of myeloid cells. First to arrive at
the site of tissue damage are the neutrophils, followed by classical monocytes. Classical
activation of these monocytes leads to the development of M1 macrophages, and
subsequently, M2 macrophages. During the earliest phases of recovery, neutrophils and
M1 macrophages promote an inflammatory environment, while M2 macrophages promote
an anti-inflammatory milieu during the late phase of recovery. Despite an inflammatory
environment, the early phase of recovery plays a pivotal role in the remodeling of skeletal
muscle. MPC are known to proliferate during the M1 phase, while the M2 phase of
recovery allows for the differentiation of MPC to mature myotubes, resulting in skeletal
muscle recovery.
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Within circulation, the myeloid cells also actively contribute to the recovery
process. The heterogeneity of monocytes within circulation has gained interest in recent
years with the formal definition of an intermediate monocyte population. Furthermore,
each monocyte subset has specific responsibilities within the context of skeletal muscle
recovery. Classical monocytes infiltrate damaged tissue and give rise to M1 macrophages,
while also displaying a strong phagocytic capacity.

Intermediate monocytes are

inflammatory cells that assist with antigen presentation to T-cells, while nonclassical
monocytes patrol the endothelial wall. As each subset has distinct responsibilities, the
propensity of each subset to adhere and transmigrate into damaged tissue is of interest.
While both classical and intermediate monocytes express the cell adhesion molecule
MAC1/CR3, examination of this marker provides an indication of the tendency of these
cells to migrate to damaged tissue.
Though many processes of the immune response have been elucidated, many
questions remain. The focus of our knowledge on the monocyte subset response to exercise
has been primarily achieved using aerobic exercise but our understanding of monocyte
subset redistribution in response to resistance exercise is lacking. Furthermore, increases
in MAC1/CR3 expression likely lead to extravasation of myeloid cells, however, the
response of different monocyte subsets, namely the inflammatory intermediate monocytes,
to resistance exercise is unknown. Additionally, polyphenol supplementation is known to
suppress the expression of MAC1/CR3 on monocytes and neutrophils. However, the
application of polyphenol supplementation to recruitment of myeloid cells following
exercise has yet to be examined. Given the necessity of macrophage infiltration for
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complete recovery of skeletal muscle, exercise and supplementation programs that
maximize myeloid extravasation may be indicative of enhanced recovery.
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CHAPTER 3: DESIGN AND METHODOLOGY

Participants
Thirty-six recreationally active males between the ages of 18 and 35 volunteered to
participate in this study. Participants were randomly assigned to one of three groups. The
first group (PPB; N=13, 21.8 ± 2.5 y, 171.2 ± 5.5 cm, 71.2 ± 8.2 kg, 24.3 ± 2.8 kg/m2)
consumed 2 g per day of the proprietary polyphenol blend supplement; the second group
(PL; N = 15, 21.6 ± 2.5 y, 176.5 ± 4.9 cm, 84.0 ± 15.7 kg, 26.9 ± 4.2 kg/m2) consumed 2 g
per day of the placebo and the third group (CON; N = 9, 23.6 ± 4.5 y, 174.0 ± 13.4 cm,
78.3 ± 16.9 kg, 25.7 ± 3.5 kg/m2) served as control. Following an explanation of all
procedures, risks and benefits, each participant provided his informed written consent prior
to completing any testing. For inclusion in the study, participants had to complete less than
three hours of planned exercise per week, have a body mass index of 18.0-34.9 kg/m2, be
free of physical limitations, and be willing to maintain a habitual diet while abstaining from
dietary supplements.

Study Design
All groups reported to the human performance lab for five days of testing (Figure
5). Prior to the first day of testing, PPB and PL completed a 28-day supplementation
protocol. Day 1 consisted of 1-repetition maximum (1-RM) testing of the squat, leg press
and leg extension exercises, and occurred at least 72 hours prior to the second day of the
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study. On day 2, participants arrived in the lab 12 hours postprandial, and provided a
resting blood sample (PRE).

After blood samples were obtained, participants were

provided a small breakfast bar (Cal: 190, CHO: 19g, Protein: 7g, Fat: 13g) and then
completed performance testing. After performance testing was complete, CON rested for
one hour, while PPB and PL began the acute exercise protocol. Participants provided blood
samples immediately post- (IP), 1-hour (1H) and 5-hours (5H) post-exercise, and
completed performance testing at 1H following the damaging protocol. Immediately
following the performance measures at 1H, participants were provided with a light meal
(Cal: 250, CHO: 34g, Protein: 14g, Fat: 6g). Participants returned to the lab in a fasted
state 24- (24H), 48- (48H) and 96-hours (96H) later for resting blood samples and
performance testing.
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Figure 5: Study Design.
Participants completed 1-RM testing at least 72 hours prior the exercise protocol.
During day 2, participants completed a muscle damaging workout, and provided
blood samples pre exercise (PRE), immediately (IP), 1 hour (1H) and 5 hours
(5H) post exercise. Performance testing was completed at PRE and 1H.
Participants provided additional blood samples and completed performance
testing 24- (24H), 48-(48H) and 96- (96H) hours following damage. Flow
cytometry was completed at every blood sampling except 96H.

Procedures

Supplementing Protocol
Both the PPB and PL groups completed daily supplementation for 28 days with
either a proprietary polyphenol blend (PPB) or placebo (PL) (Kemin Foods, L.C., Des
Moines, IA, USA). The PPB group consumed a blend of water-extracted green and black
tea (Camellia Sinensis) containing at minimum 40% total polyphenols, 1.3% theaflavins,
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5-8% epigallocatechin-3gallate (EGCG), 7-13% caffeine, 600 ppm manganese. The PL
group consumed microcrystalline cellulose in capsules of similar shape and size. All
products were tested for toxins including heavy metals, pesticides and excipients by an
independent third party.
Briefly, participants reported to the Human Performance Lab three to five days per
week to receive the supplement. Participants took one dose (1000 mg PPB or PL) under
the supervision of a member of the research team, and were given their prescribed doses in
individual containers (1000 mg PPB or PL) for each additional time point. Participants
consumed two doses per day for a total of 2000 mg of either PPB or PL daily. Participants
were asked to return all empty containers upon their next visit to the lab. Participants that
did not maintain 80% compliance in each phase (28 days of supplementation or during the
AP) were removed from analysis.

1-Repetition Maximum Testing
Direct measurement of one repetition maximal strength (1-RM) was completed on
the squat and leg press exercises, while a predicted 1-RM was performed on the leg
extension exercise. All participants completed a standardized warm-up, consisting of 5
minutes on a cycle ergometer against a self-selected resistance, 10 body weight squats, 10
walking lunges, 10 dynamic hamstring stretches and 10 dynamic quadriceps stretches. All
1-RM testing was completed as previously described (Hoffman, 2006). Briefly, each
participant completed two warm-up sets consisting of 5-10 repetitions and 3-5 repetitions
at approximately 40-60% and 60-80% of his perceived maximum, respectively. Each
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participant then performed up to five subsequent trials to determine his 1-RM with 3-5
minutes of rest between each set.
During the squat exercise, participants placed a safety squat bar (Power Lift,
Jefferson, IA, USA) across their shoulders and descended to the parallel position, where
the greater trochanter of the femur reached the same level as the knee. Participants then
ascended to a complete knee extension. Leg press was completed with the participant
sitting in a reclined position, with their legs extended. Participants were asked to lower the
weight until the lower leg and femur created a 90° angle. Participants were then asked to
press the weight up. Participants that were unable to complete the repetition or maintain
proper range of motion were given one additional opportunity. If they were still unable to
perform the exercise correctly, the last completed weight was recorded as the 1-RM.
For the leg extension exercise, participants were placed in a seated position, and
asked to extend their legs straight out in front of them. Participants were asked to perform
as many repetitions as possible, and the resulting repetitions and weight used were applied
to a prediction equation (Brzycki, 1993). If more than 10 repetitions were performed, the
weight was increased and the participant repeated the measure 3-5 minutes later. All
testing was observed by a certified strength and conditioning specialist to monitor
adherence to form.

Acute Exercise Protocol
Only PPB and PL completed the protocol, while CON rested for an hour. The
exercise protocol designed to cause muscle damage in previously untrained individuals was
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preceded by a light warm-up as described above. Following the light warm-up, participants
completed a resistance exercise session that consisted of six sets of 10 repetitions of the
squat, as well as four sets of 10 repetitions of the leg press and leg extension exercises. All
exercises were completed at 70% of the subjects previously determined 1-RM with 90 sec
of rest between each set. Participants were provided with assistance if they were unable to
complete 10 repetitions on their own, and weight for the subsequent set was reduced. All
testing sessions were observed by a certified strength and conditioning specialist to monitor
adherence to exercise form.

Blood Measurements
Blood samples were obtained at seven time points throughout the study (PRE, IP,
1H, 5H, 24H, 48H and 96H). The PRE, IP and 1H blood samples were obtained using a
Teflon cannula placed in a superficial forearm vein using a three-way stopcock with a male
luer lock adapter and plastic syringe. The cannula was maintained patent using an isotonic
saline solution (Becton Dickinson, Franklin Lakes, NJ, USA). PRE and 1H blood samples
were obtained following a 15-minute equilibration period, while IP blood samples were
taken within 5-min of exercise cessation. The remaining time points (5H, 24H, 48H and
96H) were obtained by a single use disposable needle with the subject in a supine position
for at least 15 minutes prior to sampling. Whole blood (20 ml) was collected in two
Vacutainer® tubes (Becton Dickinson, Franklin Lakes, NJ), one containing K2EDTA, and
one containing no anti-clotting agents. Aliquots were removed from the first tube for
hematocrit and hemoglobin measures, as well as flow cytometry analysis, while the second
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tube was allowed to clot for 30 minutes prior to being centrifuged at 3,000xg for 15 minutes
with the remaining whole blood from the first tube. The resulting plasma and serum was
aliquoted and stored at -80°C for later analysis.

Circulating Markers
Hematocrit was analyzed in duplicate from whole blood via microcentrifugation
(Statspin®, Critspin, Westwood, MA, USA) and microcapillary technique. Hemoglobin
was analyzed in duplicate from whole blood using an automatic analyzer (Hemocue®,
Cypress, CA, USA). Coefficient of variation for each assay was 0.20% for hematocrit and
0.46% for hemoglobin. Plasma volume shifts following the workout were calculated via
the formula established by Dill and Costill (Dill & Costill, 1974), however, circulating
values were not adjusted to account for changes in plasma volume.
Serum concentrations of myoglobin (MG) were obtained via enzyme-linked
immunosorbent assay (ELISA) (Calbiotech, Spring Valley, CA, USA), while CK was
analyzed using a commercially available kinetic assay (Sekisui Diagnostics,
Charlottetown, PE, Canada), per manufacturer’s instructions.

To limit inter-assay

variability, all samples for a particular assay were thawed once, and analyzed by the same
technician using a BioTek Eon spectrophotometer (BioTek, Winooski, VT, USA). All
samples were analyzed in duplicate with a mean coefficient of variation of 7.57% for MG
and 3.66% for CK.
Plasma concentrations of interleukin-1β (IL-1β), IL-6, IL-8, IL-10, monocytechemoattractant protein-1 (MCP-1), fractalkine (CX3CL1), interferon-γ (INF-γ)
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granulocyte colony stimulating factor (G-CSF) and granulocyte/macrophage colony
stimulating factor (GM-CSF) were analyzed via multiplex assay, using the human
cytokine/chemokine panel one (EMD Millipore, Billerica, MA, USA). All samples were
thawed once and analyzed in duplicate by the same technician using the MagPix (EMD
Millipore), with average coefficient of variation of 6.17%, 7.74%, 8.04%, 5.33%, 6.84%,
7.18%, 8.21%, 7.82%, and 7.10% for IL-1β, IL-6, IL-8, IL-10, MCP-1, CX3CL1, INF-γ,
G-CSF and GM-CSF respectively.

Flow Cytometry
Cell Preparation
Fresh, anti-coagulated (K2EDTA), whole blood (100 µl) was mixed with
fluorescent-conjugated

monoclonal

antibodies

specific

to

CD11b-fluorescein

isothiocyanate (FITC; Biolegend, San Diego, CA, USA), CD66b-phycoerythrin (PE),
CD14-PerCP Cy5.5 and CD16-allophycocyanin (APC; BD Biosciences, San Jose, CA,
USA). Samples were mixed and incubated for 15 minutes in the dark, after which, the
samples were lysed with 2 ml of 1 x FACS lysing solution (BD Biosciences), mixed and
incubated in the dark for an additional 8 minutes. Following incubation, samples were
centrifuged at 300 x g for 8 minutes and washed with 2 ml of 1 x wash buffer containing
1% fetal bovine serum (FBS) in a 1 x phosphate buffered saline (PBS) solution. Samples
were centrifuged again at 300 x g for 8 minutes, and the supernatant was removed. Samples
were then fixed in 300 µl of 2% paraformaldehyde in PBS.
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Data Acquisition and Analysis
Cell preparations were acquired using an Accuri C6 flow cytometer (BD Accuri
Cytometers, Ann Arbor, MI, USA) equipped with two lasers providing excitation at 488
and 640 nm, and 4 band pass filters (FL1: 533/30; FL2: 585/40; FL3 670LP; FL4: 675/25).
Events were recorded based on size (FSC-A), complexity (SSC-A) and mean fluorescence
intensity (MFI). A total of 200 µl were collected for each sample, which ensured at least
8,000 CD14+ events.
Analysis was completed using BD Accuri analysis software (BD Accuri
Cytometers). Events were initially gated based on SSC-H and SSC-A as a multiplet cell
exclusion criteria (Figure 6 A). Granulocytes were then determined by CD66b positive
staining (Figure 6 B, C), while monocytes were discriminated into classical, intermediate
and non-classical monocytes initially by FSC/SSC characteristics (Figure 6 D) and
secondarily by CD14 and CD16 staining characteristics (Figure 6 E) (Wong et al., 2012),
with CD66b exclusion (Figure 6 B, C) (Ziegler-Heitbrock et al., 2010). Mean fluorescence
intensity (MFI) for each of these sub-populations was then determined for CD11b (Figure
6 F). Granulocytes are expressed as a percent of leukocytes, and monocyte subsets are
presented as a percent of total monocytes.
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Figure 6: Gating Procedure.
All samples were initially gated for multiplet exclusion (A). Granulocytes were
identified by staining for CD66b in an unstained control sample (B), and
compared to samples positively stained for CD66b (C). Monocytes were initially
gated in FSC vs SSC characteristic plot with a monocyte gate (D), which were
assessed for CD66b expression (B/C). CD66b- monocytes were applied to a
CD14 vs CD16 two dimensional histogram to identify classical, intermediate and
non-classical monocytes (E). All cell subtypes were analyzed for CD11b
expression (F).

Performance Testing
Performance testing was performed at PRE, 1H, 24H, 48H and 96H, and consisted
of maximal voluntary isometric contractions, during which peak torque (PKT) and the rate
of torque development (RTD) was determined. During each assessment participants were
positioned in a BioDex S4 isokinetic dynamometer in a seated position with their hips at a
110° angle. Participants were then secured to the device with straps around the waist and
shoulders, after which, the technicians positioned the knee at a 110° angle (with 180°
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representing full extension). The participants were then prompted to kick as forcefully and
as fast as possible, while maintaining their effort for five seconds. Each participant was
provided two attempts, and the highest PKT and RTD was recorded.

Statistics
Changes in circulating cytokines, markers of muscle damage, immune cell
characteristics and performance measures were analyzed via repeated measures analysis of
variance (ANOVA). In the event of a significant F ratio, LSD post-hoc tests were used for
pairwise comparisons. Due to non-normality, circulating cytokines and markers of muscle
damage were transformed using the natural log (LN). Area under the curve (AUC) was
also calculated for changes in the cytokines and myoglobin response using a standard
trapezoidal technique. AUC was analyzed via one-way ANOVA. Raw concentrations
from PRE, IP, 1H and 5H were used to calculate AUC prior to LN transformation.
Additionally, Pearson product moment correlations were calculated to examine selected
bivariate relationships between immune cells, and markers of muscle damage measures.
Significance was accepted at an alpha level of p≤0.05 and all data are reported as mean ±
SD of the original, non-transformed data.
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CHAPTER 4: RESULTS

Participant Characteristics
Participants were required to maintain 80% compliance during the supplementation
period to be included in the final analysis. As a result, 10 participants were removed from
the investigation prior to analysis (PPB = 6; PL = 4). Of the 10 participants removed, five
participants requested to discontinue testing (PPB = 4; PL = 1). Of the five participants
that wished to discontinue, one completed a portion of the resistance exercise protocol prior
to discontinuing the study (PPB group), two reported unresolvable scheduling conflicts
(both from PPB group), and two discontinued supplementation (PPB = 1, PL = 1). Five
additional participants that completed testing were removed from analysis due to lack of
compliance (PPB = 2; PL = 3). Four of the five participants were removed for failure to
achieve 80% compliance with supplementation (PPB = 2; PL = 2) while one did not adhere
to the fasting requirements (PL group). A graphical schematic of this is displayed in Figure
7. Characteristics of the remaining 39 participants are listed in Table 3. No significant
differences were observed between groups for participant characteristics or compliance.
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Figure 7: Participant recruitment and randomization.
Participant screening through the duration of the study. Compliance was set a
priori at >80%.
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Table 3: Participant Characteristics.
Participant characteristics are listed as mean (SD)

Polyphenol
Blend (PPB)

Placebo
(PL)

Control
(CON)

p

N/A

Characteristics
n

13

15

11

Age
(Yrs)
Height
(cm)
Weight
(kg)
BMI
(kg*m-1)
Squat 1RM
(kg)
Leg Press 1RM
(kg)
Compliance
(%)

21.8
(2.5)
171.2
(5.5)
71.2
(8.2)
24.3
(2.8)
108.2
(14.4)
158.0
(41.4)
95.9
(6.6)

21.6
(2.5)
176.5
(4.9)
84.0
(15.7)
26.9
(4.2)
108.6
(30.5)
160.6
(30.5)
95.4
(6.5)

23.3
(4.1)
173.6
(12.0)
77.8
(15.6)
25.6
(3.3)
121.9
(30.7)
197.3
(72.6)
N/A

0.344
0.203
0.060
0.181
0.400
0.199
0.853

Markers of Muscle Damage
A significant group x time interaction (F = 19.16, p < 0.001, η2 = 0.523) was
observed in changes in myoglobin concentrations (see Figure 8). Post Hoc analysis
indicated a significant elevation at IP in both PPB (p = 0.004) and PL (p = 0.002) compared
to CON. Elevations were maintained at 1H and 5H for both groups (p’s < 0.001) compared
to CON. No significant differences in the myoglobin AUC response were observed
between the groups (F = 2.243; p = 0.121).
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Figure 8: Myoglobin Response to Resistance Exercise.
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for
changes in (A) Myoglobin concentration were analyzed PRE, immediately- (IP),
one- (1H) and five- (5H) hours post Changes in exercise. (B) Creatine Kinase preexercise (PRE) and 24 (24H), 48 (48H) and 96 (96H) hours after exercise.
* Significantly different than corresponding value for PRE (p < 0.05)
^ Significantly different than corresponding value for CON (p < 0.05)

Changes in circulating CK concentrations are depicted in Figure 9. A significant
group x time interaction was observed (F = 4.27, p = 0.005, η2 = 0.201) for CK
concentrations. Significant elevations from PRE were noted in both PPB and PL at 24, 48
and 96 hours). However, CK concentrations at 24H, 48H and 96H were significantly
greater in PPB compared to PL (p = 0.041, 0.025 and 0.025, respectively) and CON (p ≤
0.001); while PL was significantly greater than CON (p = 0.036) at 24H only.
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Figure 9: Creatine Kinease Response to Resistance Exercise.
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for
changes in (A) Myoglobin concentration were analyzed PRE, immediately- (IP),
one- (1H) and five- (5H) hours post Changes in exercise. (B) Creatine Kinase preexercise (PRE) and 24 (24H), 48 (48H) and 96 (96H) hours after exercise.
* Significantly different than corresponding value for PRE (p < 0.05)
^ Significantly different than corresponding value for CON (p < 0.05)
# Significantly different than corresponding value for PL (p < 0.05)

Changes in Maximal Voluntary Isometric Contractions
Changes in peak torque in response to resistance exercise are depicted in Figure 10.
A significant group x time interaction was observed for percent change in peak torque (F
= 4.52, p = 0.001, η2 = 0.201). Significant reductions from PRE were noted for PPB and
PL for every measure (1H – 96H) and for CON from 24H – 48H. The percent reduction
from PRE in peak torque at 1H was significantly greater in PBB (p = 0.001) and PL (p =
0.001) compared to CON. No other between group differences were noted.
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Figure 10: Maximal Voluntary Isometric Torque following Resistance Exercise.
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for
changes in maximal voluntary isometric (A) peak torque and (B) rate of torque
development. Changes are assessed as percent difference from pre exercise to
one- (1H), 24- (24H), 48- (48H), and 96- (96H) hours post exercise.
* Significantly different than corresponding value for PRE (p < 0.05)
^ Significantly different than corresponding value for CON (p < 0.05)

Circulating Cytokines
Changes in circulating MCP-1 in response to resistance exercise are depicted in
Figure 11. A significant group x time interaction was observed between groups (F = 3.17,
p = 0.003, η2 = 0.150). Significant differences were noted at 5H between CON and both
PPB (p < 0.001) and PL (p = 0.006). Additionally, a trend (p = 0.081) for a difference was
also noted between CON and PPB at 1H. Furthermore, a significant interaction between
groups was observed for AUC of MCP-1 (F = 4.338, p = 0.021) (Figure 12). AUC for the
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MCP-1 response was significantly greater (p = 0.006) in PPB than CON, and trended
toward a difference (p = 0.093) when compared to PL.
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Figure 11: Monocyte Chemoattractant protein-1 (MCP-1) Response to Resistance
Exercise.
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for
changes in MCP-1 pre exercise (PRE), as well as immediately (IP), one- (1H),
five- (5H), 24- (24H), 48- (48H) and 96- (96H) hours post exercise.
* Significantly different than corresponding value for PRE (p < 0.05)
^ Significantly different than corresponding value for CON (p < 0.05)
# Significantly different than corresponding value for PL (p < 0.05)
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Figure 12: Monocyte Chemoattractant protein-1 (MCP-1) Area under the Curve
Response to Resistance Exercise.
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for
Area under the curve comparison between PPB, PL and CON.
* Significantly different than CON (p < 0.05)

No significant group x time interaction was observed for CX3CL1 (F = 1.081, p =
0.380, η2 = 0.060), however a significant time effect was observed (F = 16.118, p < 0.001,
η2 = 0.322). When collapsed across groups, pairwise comparisons indicated significant
elevations from PRE (149.1 ± 84.9 pg/ml) at IP (184.7 ± 70.9 pg/ml; p < 0.001) and 1H
(171.9 ± 73.8 pg/ml; p = 0.002), and suppression at 48H (130.5 ± 66.4 pg/ml; p = 0.025).
In addition, elevations at IP was significantly higher than 5H (165.2 ± 107.8 pg/ml; p =
0.007), 24H (138.9 ± 74.3 pg/ml; p < 0.001), 48H (p < 0.001) and 96H (p < 0.001), while
1H and 5H were significantly elevated over 24H (p < 0.001, p < 0.001, respectively), 48H
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(p < 0.001, p < 0.001, respectively) and 96H (p < 0.001, p = 0.011, respectively).
Furthermore, no significant interaction was observed for the CX3CL1 AUC response
between groups (F = 0.0859, p = 0.433).
No significant group x time interactions were observed for changes in IL-1β (F =
0.47, p = 0.849, η2 = 0.027), however a significant time effect was observed (F = 17.57, p
< 0.001, η2 = 0.341). Pairwise comparisons indicated that when collapsed across groups,
significant elevations (p’s < 0.001) from PRE (4.23 ± 2.34 pg/ml) were observed at IP (7.55
± 5.77 pg/ml) and 1H (6.67 ± 4.89 pg/ml), 5H (4.79 ± 3.52 pg/ml), 24H (4.19 ± 2.91 pg/ml),
48H (3.97 ± 3.34 pg/ml) and 96H (3.71 ± 2.39 pg/ml). When compared to 5H, IL-1β
concentrations trended to be lower at 48H (p = 0.08) but significantly lower at 96H (p =
0.015). No significant differences were observed in the IL-1β AUC response between
groups (F = 0.101; p = 0.904).
No significant group x time interaction was observed for IL-6 (F = 1.018, p = 0.422,
η2 = 0.055), however a significant time effect was observed (F = 4.801, p = 0.002, η2 =
0.121).

When groups were collapsed, pairwise comparisons indicated a significant

increase in IL-6 concentration from PRE (33.2 ± 42.9 pg/ml) at IP (35.2 ± 44.7 pg/ml; p =
0.044), 1H (37.7 ± 48.7 pg/ml; p = 0.004) and 5H (42.5 ± 51.4 pg/ml; p = 0.002).
Additionally, 5H was significantly elevated compared to 24H (38.4 ± 49.8 pg/ml; p =
0.001), 48H (37.1 ± 50.1 pg/ml; p = 0.003) and 96H (28.0 ± 31.6 pg/ml; p = 0.010).
Furthermore, no significant differences were observed in the IL-6 AUC response between
the groups (F = 0.815, p = 0.451).
No significant group x time interaction (F = 0.801, p = 0.532, η2 = 0.044) was
observed for IL-10, however, a significant main effect of time was observed (F = 5.608, p
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= 0.005, η2 = 0.138). Pairwise comparisons indicated that when groups were collapsed,
IL-10 concentrations were significantly elevated at 1H (21.09 ± 15.16 pg/ml) compared to
PRE (12.84 ± 14.67 pg/ml, p < 0.001), IP (16.80 ± 14.93 pg/ml; p = 0.009), 5H (14.45 ±
19.41 pg/ml; p = 0.012), 24H (13.15 ± 14.79 pg/ml; p < 0.001), 48H (13.08 ± 15.38 pg/ml;
p < 0.001), and 96H (11.39 ± 11.24; p < 0.001). In addition, IL-10 concentrations at IP
were significantly higher than PRE (p = 0.001), 24H (p = 0.008), 48H (p = 0.018) and 96H
(p = 0.002). The IL-10 AUC response between groups was not different (F = 2.178, p =
0.128).
No significant group x time interaction (F = 0.876, p = 0.534, η2 = 0.052) was
observed for G-CSF, however a significant main effect for time was observed (F = 7.415,
p < 0.001, η2 = 0.188). When groups were collapsed, pairwise comparisons indicated
significant elevations from PRE (72.3 ± 37.0 pg/ml) at IP (92.2 ± 55.6; p < 0.001), 1H
(84.9 ± 40.7 pg/ml; p = 0.011) and 5H (80.8 ± 36.3 pg/ml; p = 0.025). Additionally, IP,
1H and 5H were significantly greater than 24H (71.3 ± 40.5 pg/ml; p = 0.001, p = 0.006, p
= 0.001, respectively), 48H (70.6 ± 49.1 pg/ml; p = 0.003, p = 0.004, p = 0.001,
respectively) and 96H (65.8 ± 28.3 pg/ml; p = 0.001, p = 0.001, p < 0.001, respectively).
No significant between group differences were observed for the G-CSF AUC response (F
= 0.146, p = 0.732).
No significant group x time interactions were observed for GM-CSF (F = 0.501, p
= 0.863, η2 = 0.028), however, a significant main effect for time was observed (F = 8.238,
p < 0.001, η2 = 0.192). When groups were collapsed, pairwise comparisons indicated a
significant elevation from PRE (54.99 ± 51.38 pg/ml) at IP (75.36 ± 94.35 pg/ml, p < 0.001)
and 1H (73.31 ± 98.20 pg/ml, p = 0.007). GM-CSF was also significantly greater at IP and
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1H than 5H (68.40 ± 87.97 pg/ml; p = 0.013, p = 0.049, respectively), 24H (61.48 ± 78.97
pg/ml; p < 0.001, p = 0.001, respectively), 48H (59.86 ± 70.52 pg/ml; p < 0.001, p = 0.001,
respectively) and 96H (52.56 ± 62.91 pg/ml; p < 0.001, p < 0.001, respectively). In
addition, GM-CSF concentrations at 5H were significantly greater than 48H (p = 0.049)
and 96H (p = 0.040). No significant differences were noted between the groups in the GMCSF AUC response (F = 0.315, p = 0.732).
No significant group x time interactions (F = 1.169, p = 0.321, η2 = 0.063 and F =
0.385, p = 0.855, η2 = 0.022), were observed for changes in IL-8 and INF-γ concentrations,
respectively. In addition, no differences were noted in the AUC response (F = 0.122, p =
0.885, and F = 0.365, p = 0.697, respectively) for these cytokine markers as well.

Plasma Volume Shifts
A significant group x time interaction was observed for changes in plasma volume
(F = 10.94, p < 0.001, η2 = 0.378). Changes in plasma volume at IP were significantly less
in CON (-1.4 ± 4.6%) compared to PPB (-17.7 ± 5.8%; p < 0.001) and PL (-15.1 ± 4.3%;
p < 0.001). Furthermore, PL (0.7 ± 3.7%) was significantly greater than PPB (-4.0 ± 7.3%;
p = 0.037) and CON (-4.5 ± 5.8%; p = 0.028). Circulating markers were not corrected for
changes in plasma volume.
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Leukocyte Population Distributions
Changes in the proportion of granulocytes in circulation in response to resistance
exercise are depicted in Figure 13. A significant group x time interaction was observed in
the proportion of circulating granulocytes (F = 5.150, p < 0.001, η2 = 0.233). Granulocyte
proportions at IP were significantly higher in CON compared to PPB (p = 0.004).
Furthermore, a trend towards a difference was noted at IP between CON and PL (p =
0.073). Additionally, the proportion of granulocytes in CON at 5H was significantly lower
compared to PPB (p = 0.022) and PL (p = 0.013). Granulocyte proportion for PL was
significantly greater at 48H than CON (p = 0.026) or PPB (p = 0.022).
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Figure 13: Circulating Granulocyte Proportions following Resistance Exercise.
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for
changes in the circulating granulocyte proportions pre exercise (PRE), as well as
immediately (IP), one- (1H), five- (5H), 24- (24H), and 48- (48H) hours post
exercise.
* Significantly different than corresponding value for PRE (p < 0.05)
^ Significantly different than corresponding value for CON (p < 0.05)
# Significantly different than corresponding value for PL (p < 0.05)

Changes in monocyte subset distributions in response to resistance exercise are
depicted in Figure 14. A significant group x time interaction was observed for the
proportion of classical monocytes of the total monocyte population (F = 0.9552, p < 0.001,
η2 = 0.381). The proportion of classical monocytes were significantly greater in CON at
IP compared to PPB (p = 0.008) and PL (p = 0.003). Furthermore, classical monocytes
were significantly reduced in CON at 1H compared to PPB (p = 0.002) and PL (p = 0.006).
A significant group x time interaction was observed for the proportion of
intermediate monocytes of the total monocyte population (F = 7.765, p < 0.001, η2 = 0.334).
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The proportion of intermediate monocytes were significantly lower in CON at IP compared
to PPB (p = 0.034) and PL (p = 0.001). Furthermore, this response was reversed at 1H
with significantly greater proportions of intermediate monocytes in CON compared to PPB
(p = 0.003) and PL (p = 0.008). At 24H, the proportion of intermediate monocytes in CON
were significantly lower compared to PPB (p = 0.016), and trended towards difference in
PL (p = 0.094).

At 48H, the proportion of intermediate monocytes in CON were

significantly lower compared to PPB (p = 0.007) and PL, and PL trended to be lower than
PPB (p = 0.079).
A significant group x time interaction was also observed for the proportion of
nonclassical monocytes of the total monocyte population (F = 6.543, p < 0.001, η2 = 0.297).
The proportion of intermediate monocytes at IP was significantly lower in CON compared
to PPB (p = 0.020) and PL (p = 0.028).
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Figure 14: Monocyte Subtype Proportions following Resistance Exercise.
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for changes in the monocyte subtype proportions
pre exercise (PRE), as well as immediately (IP), one- (1H), five- (5H), 24- (24H), and 48- (48H) hours post exercise.
* Significantly different than corresponding value for PRE (p < 0.05)
^ Significantly different than corresponding value for CON (p < 0.05)
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Leukocyte Subtype Activation
Significant differences were observed between groups at PRE for CD11b
expression on granulocytes (F = 5.334, p = 0.010), intermediate monocytes (F = 3.594, p
= 0.039) and nonclassical monocytes (F = 7.942, p = 0.002). As such, analyses between
groups for expression of CD11b on all leukocyte subsets were analyzed as the percent of
resting values (PRE set at 100%).
No significant group x time interaction was observed for the percent change in
CD11b expression on granulocytes (F = 1.022, p = 0.421, η2 = 0.057), however a significant
main effect for time was observed (F = 12.059, p < 0.001, η2 = 0.262). When collapsed
across groups , pairwise comparisons indicated that the change in expression of CD11b on
granulocytes from PRE to IP (121.6 ± 30.1%; p < 0.001) and 1H (110.5 ± 24.9%; p =
0.015) were significant, while a trend for a significant change in CD11b on granulocytes
from PRE to 24H (106.9 ± 23.6%; p = 0.086) was also observed. Additionally, the change
from PRE to IP was significantly greater than the change from PRE to 1H (p = 0.001), 5H
(99.5 ± 24.3%; p < 0.001), 24H (p = 0.001) and 48H (96.1 ± 19.9%; p < 0.001).
Furthermore, the change in CD11b expression on granulocytes from PRE to 1H was
significantly greater than the change from PRE to 5H (p = 0.016) and 48H (p = 0.001).
No significant group x time interaction was observed for the percent change in
expression of CD11b on classical monocytes (F = 1.788, p = 0.111, η2 = 0.101), however
a significant main effect time was observed (F = 9.663, p < 0.001, η2 = 0.232). When
collapsed across groups, pairwise comparisons indicated that the change from PRE to 1H
(130.7 ± 29.8%), 5H (111.2 ± 28.8%), and 24H (113.5 ± 25.9%) were significant (p <
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0.001, p = 0.033, p = 0.004, respectively). Additionally, the change of CD11b expression
from PRE to 1H was significantly greater than the change from PRE to IP (109.4 ± 33.4%;
p < 0.001), 5H (p = 0.004), 24H (p < 0.001) and 48H (102.3 ± 20.7%; p < 0.001), while
the change from PRE to 24H was significantly greater than the change from PRE to 48H
(p = 0.002).
No significant group x time interaction was observed for the percent change of
CD11b expression on intermediate monocytes (F = 1.859, p = 0.083, η2 = 0.104), however
a significant main effect of time was observed (F = 5.667, p = 0.001, η2 = 0.150). When
collapsed across groups, pairwise comparisons revealed the change from PRE to 1H (116.6
± 20.7%) was significant (p < 0.001), while the change from PRE to 24H trended toward
significance (105.8 ± 18.3%; p = 0.070). Additionally, the change from PRE to 1H was
significantly greater than the change from PRE to IP (104.9 ± 26.55%; p = 0.003), 5H
(102.0 ± 23.0%; p = 0.001), 24H (p = 0.001) and 48H (100.5 ± 15.9%; p < 0.001).
Additionally, the change in expression of CD11b at from PRE to 24H was significantly
greater than the change from PRE to 48H (p = 0.029).
No significant group x time interaction (F = 1.917, p = 0.084, η2 = 0.107), nor main
effect of time (F = 2.099, p = 0.104, η2 = 0.062) was observed for the percent change of
CD11b expression on nonclassical monocytes; however, a significant main effect for group
(F = 4.409, p = 0.020, η2 = 0.216) was observed. Pairwise comparisons indicated that the
average percent change from PRE to all time points in CD11b expression on nonclassical
monocytes was lower in CON (89.1 ± 13.4%) compared to PPB (106.0 ± 13.8; p = 0.006),
while no differences were observed between CON or PPB and PL (97.6 ± 12.3%; p =
0.0121, p = 0.106, respectively).
85

Correlations
Significant correlations were observed between markers of muscle damage and
changes in CD11b expression on leukocyte subsets. CK concentrations at 24H were
significantly correlated with the change in CD11b expression on intermediate monocytes
at IP (r = 0.439, p = 0.001), and nonclassical monocytes at IP (r = 0.413, p = 0.017), 1H (r
= 0.392, p = 0.024) and 5H (r = 0.374, p = 0.032). Furthermore, 48H CK concentrations
were significantly correlated with the change in CD11b expression at IP on granulocytes
(r = 0.340, p = 0.045), classical monocytes (r = 0.365, p = 0.037), and intermediate
monocytes (r = 0.452, p = 0.008). Additionally, the change in CD11b expression on
nonclassical monocytes was correlated at IP (r = 0.450, p = 0.009), 1H (r = 0.402, p =
0.020), 5H (r = 0.345, p = 0.049), 24H (r = 0.446, p = 0.009) and 48H (r = 0.495, p =
0.003). No correlations were observed between the change of CD11b expression on
leukocytes and myoglobin AUC. Correlations with leukocyte subset proportions are
displayed in Table 4.

86

Table 4: Leukocyte Subset Correlations with Markers of Muscle Damage

IP
1H
5H
24H
48H

r
p
r
p
r
p
r
p
r
p

Myoglobin AUC
GRAN CLASS INTER
NC
-0.515
-0.664
0.775
0.001
<0.001
<0.001
-0.374
-0.359
0.535
0.025
0.040
0.001
-0.548
0.568
0.001
0.001
-0.543
0.609
0.001
<0.001
-0.408
-0.640
0.412
0.631
0.013
<0.001
0.017 <0.001

24H CK Concentration
GRAN CLASS INTER
NC
-0.635
-0.692
0.719
<0.001 <0.001
<0.001
-

-0.361
0.042
-0.466
0.007
-0.565
0.001
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48H CK Concentration
GRAN CLASS INTER
NC
-0.565
-0.583
0.399
0.555
<0.001
<0.001
0.024
0.001

-

-

-

-

-

-

-

-

-

-

-

-

-0.434
0.013
-0.457
0.009

0.380
0.032
0.387
0.029

0.452
0.009

0.434
0.013
0.471
0.006

-

0.361
0.042

CHAPTER 5: DISCUSSION

The results of this study demonstrated significant alterations in the monocyte
proportions following acute resistance exercise.

Exercise produced significant

mobilization of intermediate and nonclassical monocyte subtypes immediately following
resistance exercise, followed by a supercompensation of the classical subset. As expected,
resistance exercise stimulated an increase of MCP-1 concentrations immediately following
exercise, but our results indicated a biphasic response occurring at 5H. Furthermore,
CD11b expression was elevated on granulocytes immediately following resistance
exercise, and remained elevated for one hour. Classical and intermediate monocytes
increased expression of CD11b 1-hr following exercise, while only classical monocytes
maintained this elevated expression for 24-hr. Our results also suggest that polyphenol
supplementation enhanced the CD11b response to exercise on nonclassical monocytes.
Lower resting expressions of CD11b on intermediate and nonclassical monocytes in PBB
compared to PL and CON suggest that supplementation may have suppressed this immune
marker. Markers of muscle damage, resulting from the exercise protocol, were greater with
polyphenol supplementation, and moderately correlated to leukocyte subset distributions,
as well as to CD11b expression following exercise (r = 0.359 to 0.775).
Skeletal muscle damage produces a potent immune response, characterized by an
increased accumulation of phagocytic cells within the damaged tissue (Tidball & Villalta,
2010). MCP-1 plays an integral role in the acute immune response by serving as the
primary chemoattractant for classical monocytes (Wong et al., 2012; Yadav et al., 2010).
Our results indicated that resistance exercise may mediate a biphasic response of MCP-1
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to resistance exercise, characterized by an initial increase immediately following exercise,
and a second, larger increase at 5H.
To the best of our knowledge, only two investigations have examined the acute
response of circulating MCP-1 following dynamic resistance exercise (Ihalainen et al.,
2014; Wells et al., 2016). The immediate increase of MCP-1 observed in this study is in
contrast to the decrease in MCP-1 concentration reported 30-min following resistance
exercise in untrained men (Ihalainen et al., 2014). However, it is similar to the immediate
increase reported following a lower body resistance exercise protocol in resistance trained
men (Wells et al., 2016). While Ihalainen et al. (2014) utilized a similar population as this
study (e.g., previously untrained men), the exercise stimulus used multiple sets of a single
leg press exercise only. In contrast, this study required participants to exercise with
multiple lower body exercises, similar to Wells and colleagues (2016). The greater volume
of repetitions performed in this study (140 total repetitions compared to 50 in the Ihlalainen
et al study) suggest that the immediate increase in MCP-1 following resistance exercise
may be driven by volume of exercise, and may be independent of training status. The
biphasic response observed though, was absent from any previous study examining the
MCP-1 response to resistance exercise (Ihalainen et al., 2014; Wells et al., 2016).
However, investigations examining exercise interventions designed to elicit muscle
damage have observed the secondary response approximately 5-hr into recovery (Crystal
et al., 2013; Paulsen et al., 2005). Furthermore, the participants used in those studies were
moderately trained (Crystal et al., 2013; Paulsen et al., 2005), and comparable to the
participants used in this study. Therefore, the biphasic response of MCP-1 may also be a
function of both volume in conjunction with unaccustomed muscle action.
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The recruitment of other monocyte subsets is governed primarily by CX3CL1
(Bazan et al., 1997). Circulating CX3CL1 concentrations increased at both IP and 1H for
all groups combined. These results were similar to others that reported increases in
circulating CX3CL1 concentrations for two hours following unilateral cycling (Catoire et
al., 2014). These investigators also reported a significant increase in mRNA expression of
CX3CL1 within skeletal muscle immediately after exercise. Significant increases of
CX3CL1 mRNA has also been reported two hours post-resistance exercise (Della Gatta et
al., 2014) Although Della Gatta and colleagues (2014) did not examine changes in
CX3CL1 concentrations following exercise, they did indicate that mRNA expression
returned to baseline levels at 4-hr post-exercise. CX3CL1 is synthesized by endothelial
cells (Ludwig et al., 2002), and will remain bound to the endothelial surface unless cleaved
in the presence of TNF-α and IL-1β (Turner et al., 2010). Interestingly, the results of this
study indicated that IL-1β was elevated concomitantly with CX3CL1 at both IP and 1H. It
is likely that elevations in circulating CX3CL1 concentrations were related to the
elevations observed in IL-1β.
IL-8 is also a potent chemoattractant for phagocytic cells, namely neutrophils
(Ribeiro et al., 1991). However, we saw no change in IL-8 concentrations in response to
resistance exercise. This is in contrast with some investigators (Nieman et al., 2004), but
is supported by others (Buford et al., 2009). Training status does not appear to have
influenced these results, as most investigations utilized trained participants (Buford et al.,
2009; Nieman et al., 2004; Ross et al., 2010). However, the volume of exercise used in
this study (140 total repetitions) was less than that of Nieman and colleagues (2004) (four
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sets of 10 repetitions in 10 different exercises), and may not have been sufficient to elicit a
significant increase in IL-8 concentrations.
Expansion of the granulocytic population in this study occurred despite the absence
of any change in IL-8 concentrations. This was a bit surprising considering IL-8 is a potent
chemoattractant for neutrophils (Ribeiro et al., 1991).

However, the expansion of

neutrophils, in the absence of increases of IL-8 in circulation has been reported previously
(Paulsen et al., 2005), indicating the IL-8 response may not be necessary for granulocytic
expansion. In the present study, granulocytes appeared to make up a greater proportion of
total leukocytes at 1H, 5H and 24H following exercise. Selective expansion of the
granulocyte population is well documented following resistance exercise (Miles et al.,
1998; Nieman et al., 2004; Ramel et al., 2003), and exercise designed to elicit muscle
damage (Paulsen et al., 2005). Evidence from a muscle damaging study has demonstrated
neutrophils to return to baseline concentrations 24-hr following exercise (Paulsen et al.,
2005). Despite this, granulocytes are thought to increase immediately following exercise
for approximately two hours following resistance exercise (Freidenreich & Volek, 2012).
Investigations examining resistance exercise typically do not report the overall granulocyte
population following 24 hours of recovery in healthy participants (Miles et al., 1998;
Nieman et al., 2004; Ramel et al., 2003). The expansion of the granulocyte population at
24H in this study, however, suggests that granulocytosis may be more prolonged following
dynamic resistance exercise than previously reported.
Mobilization of monocytes following resistance exercise has also been
demonstrated in conjunction with granulocyte expansion (Mayhew et al., 2005; Nieman et
al., 2004; Ramel et al., 2003). The response of specific monocyte subtypes though, has yet
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to be defined in regards to resistance exercise. In this study, we observed the mobilization
of both intermediate and nonclassical monocytes immediately following exercise at the
expense of the classical monocyte subset. While selective mobilization of the CD16+
subset may be induced by catecholamines (Kittner et al., 2002), the intensity of exercise
also appears to drive this response (Steppich et al., 2000).

Previous investigations

examining the monocyte response to exercise under the three subset paradigm have
demonstrated this mobilization to be primarily from the nonclassical subset (Booth et al.,
2010; Radom-Aizik et al., 2014; Shantsila et al., 2012; Simpson et al., 2009). LaVoy and
colleagues (2015) demonstrated an increased proportion of both intermediate and
nonclassical monocytes following aerobic exercise in a mixed gender group of participants.
Women though appear to have a different response of nonclassical monocytes to exercise
than men (Heimbeck et al., 2010). Considering that participants in this study were men
only, the increase in intermediate monocyte proportions observed immediately following
exercise appears to be related to the resistance exercise protocol itself.
Increases of intermediate monocytes at 24H and 48H following exercise occurred
at the expense of the classical monocyte subset, with no change in the nonclassical
proportion. Furthermore, PPB demonstrated a significantly greater intermediate monocyte
population than CON, with a trend compared to PL (p = 0.079) at 48H. Although data
from ischemic tissue damage has demonstrated significant elevations in intermediate
monocytes 24 and 48 hours following injury (Tapp, Shantsila, Wrigley, Pamukcu, & Lip,
2012; Urra et al., 2009), there does not appear to be any previous investigation that has
examined monocyte subsets in response to exercise 24 or 48 hours into recovery. Tapp
and colleagues (2012) have also reported that changes in intermediate monocytes were
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associated with the extent of tissue damage. Consequently, the increased intermediate
monocyte proportion in PPB at 48H was likely a result of greater muscle damage.
Furthermore, the significant correlations observed in this study (r = 0.380 to 0.452)
between markers of muscle damage and the intermediate monocyte proportion at 24H and
48H support the potential relationship between tissue damage and intermediate monocyte
mobilization.
The coupling of CD11b with CD18 to form MAC1/CR3, and its involvement within
the transendothelial migration process (Tan, 2012) makes CD11b a key regulator of
phagocyte migration to damaged tissue (Ley et al., 2007). Granulocytes migrate to
damaged tissue within the first hours following exercise, monocytes tend to migrate later
(Malm et al., 2000; Paulsen et al., 2010). The increased CD11b expression on granulocytes
at IP and 1H, followed by classical monocytes at 1H, 5H and 24H observed in this study is
consistent with the temporal appearance of these cells within damaged tissue. While the
reported time course of CD11b expression on monocytes has been more consistent than on
granulocytes, little consensus as to the time course of the granulocyte expression of CD11b
has been developed (J. Peake et al., 2005).
Investigations utilizing aerobic exercise (Jordan et al., 1999; van Eeden et al., 1999)
and exercise designed to elicit muscle damage (J. M. Peake, K. Suzuki, G. Wilson, et al.,
2005; Pizza et al., 1996; Saxton et al., 2003) have previously examined CD11b expression
on granulocytes. However, no studies have examined the impact of dynamic resistance
exercise on CD11b expression on granulocytes. Our results indicate that resistance
exercise can stimulate increases in CD11b expression on granulocytes at IP and 1H. These
results are similar to previous investigations examining endurance exercise protocols.
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Various studies have reported significant increases immediately following exercise
(Gabriel & Kindermann, 1998; Jordan et al., 1999; van Eeden et al., 1999), which may
persist for up to 30-min post-exercise (van Eeden et al., 1999). However, our results appear
to differ in comparison to studies using eccentric exercise protocols. Following downhill
running, Peake and colleagues (2005) reported no changes in CD11b expression during the
recovery period in well-trained men.

Similarly, studies examining 50 eccentric

contractions of the quadriceps (Saxton et al., 2003) or 25 eccentric contractions of the
elbow flexors (Pizza et al., 1996) in moderately trained men, reported no change in CD11b
expression up to 24 hours post-exercise. However, these latter studies first measured
CD11b expression at 4- and 1.5-hr, respectively, post-exercise. We observed an increase
in the expression of CD11b on granulocytes at IP and 1H, which was prior to any of the
measurements assessed by Saxton et al. (2003) or Pizza et al. (1996). Pizza and colleagues
(1996) though, did demonstrate a significant increase in CD11b expression 24 hours
following their damaging protocol. The results of this study provides some support as we
indicated a trend for an increased expression at 24H (p = 0.086).
Expression of CD11b on monocytes has been more extensively examined than
granulocytes. Previous reports have demonstrated elevated CD11b expression on classical
monocytes immediately and 1-hr post-exercise (Wells, et al. 2014). Other investigations
have reported no increase immediately, but significant increases 30-min following a similar
exercise stimulus in trained men (Gonzalez et al., 2014; Jajtner et al., 2014). The disparity
in the time course reported between the studies may be due to the monocyte population
examined.

Wells and colleagues (2016) analyzed classical monocytes only

(CD14++/CD16-), while Jajtner et al. (2014) and Gonzalez et al. (2014) utilized CD14++
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monocytes without differentiating between classical and intermediate monocytes.
Consequently, Wells et al. (2016) suggested that the response of CD14++ monocytes may
have been influenced by intermediate monocytes, contributing to the lack of any change
immediately post-exercise (Gonzalez et al., 2014; Jajtner et al., 2014). The delayed
increase of CD11b expression on intermediate monocytes in this study supports this
suggestion. However, the delayed expression of CD11b on classical monocytes observed
from 1H to 24H contrasts with Wells et al. (2016). Training status of the participants may
explain the different results, as this study used untrained participants while Wells et al.
(2016) investigated resistance-trained individuals. This study also observed a significant
increase in CD11b expression on classical monocytes at 24H. Previous investigations have
only examined CD11b expression on CD14++ following resistance exercise in trained men
(Gonzalez et al., 2014; Jajtner et al., 2014). This appears to be the first study to examine
CD11b expression on monocyte subsets 24 and 48H following exercise.
Polyphenol supplementation (PPB) for 28 days also appeared to reduce CD11b
expression on intermediate and nonclassical monocytes at rest compared to CON and PL.
CD11b expression on monocytes was not examined prior to the onset of supplementation,
therefore we can only speculate in relating this decreased expression of CD11b to
polyphenol supplementation. However, there does appear to be support for this from an in
vitro model, which demonstrated a significant downregulation of CD11b, as well as
reduced chemotaxis and adherence in response to incubation with polyphenols (Kawai et
al., 2004; Takano et al., 2004). However, others have suggested that decreases in CD11b
expression on monocytes may have beneficial health benefits, as polyphenol associated
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decreases in CD11b expression on monocytes has been previously reported to have
potential beneficial effects in cardiovascular disease (Chiva-Blanch et al., 2012).
In this study, no differences in the time course of CD11b expression were observed
between groups for classical or intermediate monocytes. However, participants in PPB
demonstrated a greater change in CD11b expression on nonclassical monocytes during 48hr of recovery than CON. While the expression of CD11b on nonclassical monocytes is
reduced compared to other subsets (Cros et al., 2010; Wong et al., 2011; Zawada et al.,
2011), it is unclear why this difference occurred. Nonetheless, the role of CD11b in
transendothelial migration (Ley et al., 2007), and the propensity of nonclassical monocytes
to polarize to M2 macrophages (Auffray et al., 2007) may indicate no deleterious effects
on recovery. Furthermore, it is unclear if reduced CD11b expression on classical and
intermediate monocytes throughout the recovery process is detrimental to functional
recovery. Therefore, polyphenol supplementation may serve as a potential treatment
option to decrease adherence and chemotaxis of monocytes, without affecting the exercise
response; however, further research is warranted.

Conclusions
The present study investigated the impact of an acute bout of resistance exercise in
untrained participants on the redistribution of monocyte subsets, as well as the expression
of adhesion molecules on the surface of phagocytic cells.

Circulating MCP-1

concentrations demonstrated a biphasic response to resistance exercise, with an initial
increase immediately following exercise, and a second pronounced increase five hours into
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recovery. This appears to be the first study to report a sustained increase in the proportion
of granulocytes in relation to total leukocyte population up to 24-hr post-resistance
exercise. The monocyte subset response to resistance exercise was characterized by a
mobilization of intermediate and nonclassical monocytes immediately following exercise,
followed by a supercompensation of classical monocytes 1-hr post-exercise. This study
also appears to be the first investigation to report a significant increase in the intermediate
monocyte subset 24- and 48-hr following exercise. Polyphenol supplementation, possibly
due to increased muscle damage, increased the proportion of intermediate monocytes 48H
following exercise. The results of this study indicated that an acute bout of resistance
exercise in untrained individuals elicits selective mobilization and adherence
characteristics of phagocytic cells throughout recovery. Polyphenol supplementation
appears to augment the resting expression of CD11b, however, does not affect the exercise
response of classical and intermediate monocytes, or granulocytes.

97

APPENDIX A: UCF IRB APPROVAL LETTER

98

99

APPENDIX B: NEIRB APPROVAL LETTER

100

101

102

APPENDIX C: RECRUITMENT FLYER

103

104

APPENDIX D: RECRUITMENT SCRIPT

105

106

APPENDIX E: INFORMED CONSENT

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

APPENDIX F: MEDICAL HISTORY QUESTIONNAIRE

122

123

124

125

126

127

128

APPENDIX G: PHYSICAL ACTIVITY READINESS QUESTIONNAIRE

129

130

APPENDIX H: NEIRB STUDY CLOSEOUT CONFIRMATION

131

132

REFERENCES
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000). A clonogenic common
myeloid progenitor that gives rise to all myeloid lineages. Nature, 404(6774), 193197. doi: 10.1038/35004599
Ambarus, C. A., Krausz, S., van Eijk, M., Hamann, J., Radstake, T. R., Reedquist, K. A., .
. . Baeten, D. L. (2012). Systematic validation of specific phenotypic markers for
in vitro polarized human macrophages. J Immunol Methods, 375(1-2), 196-206.
doi: 10.1016/j.jim.2011.10.013
Ancuta, P., Liu, K. Y., Misra, V., Wacleche, V. S., Gosselin, A., Zhou, X., & Gabuzda, D.
(2009). Transcriptional profiling reveals developmental relationship and distinct
biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics, 10,
403. doi: 10.1186/1471-2164-10-403
Ancuta, P., Moses, A., & Gabuzda, D. (2004). Transendothelial migration of CD16+
monocytes in response to fractalkine under constitutive and inflammatory
conditions. Immunobiology, 209(1-2), 11-20. doi: 10.1016/j.imbio.2004.04.001
Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., & Gabuzda, D.
(2003). Fractalkine preferentially mediates arrest and migration of CD16+
monocytes. J Exp Med, 197(12), 1701-1707. doi: 10.1084/jem.20022156
Arakawa, M., Mita, T., Azuma, K., Ebato, C., Goto, H., Nomiyama, T., . . . Watada, H.
(2010). Inhibition of monocyte adhesion to endothelial cells and attenuation of
atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.
Diabetes, 59(4), 1030-1037. doi: 10.2337/db09-1694
Arent, S. M., Senso, M., Golem, D. L., & McKeever, K. H. (2010). The effects of
theaflavin-enriched black tea extract on muscle soreness, oxidative stress,
inflammation, and endocrine responses to acute anaerobic interval training: a
randomized, double-blind, crossover study. J Int Soc Sports Nutr, 7(1), 11. doi:
10.1186/1550-2783-7-11
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., . . .
Chazaud, B. (2007). Inflammatory monocytes recruited after skeletal muscle injury
switch into antiinflammatory macrophages to support myogenesis. J Exp Med,
204(5), 1057-1069. doi: 10.1084/jem.20070075
Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., . . . Geissmann,
F. (2007). Monitoring of blood vessels and tissues by a population of monocytes
133

with
patrolling
behavior.
10.1126/science.1142883

Science,

317(5838),

666-670.

doi:

Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., . . . Schall, T. J.
(1997). A new class of membrane-bound chemokine with a CX3C motif. Nature,
385(6617), 640-644. doi: 10.1038/385640a0
Booth, S., Florida-James, G. D., McFarlin, B. K., Spielmann, G., O'Connor, D. P., &
Simpson, R. J. (2010). The impact of acute strenuous exercise on TLR2, TLR4 and
HLA.DR expression on human blood monocytes induced by autologous serum. Eur
J Appl Physiol, 110(6), 1259-1268. doi: 10.1007/s00421-010-1616-2
Bowtell, J. L., Sumners, D. P., Dyer, A., Fox, P., & Mileva, K. N. (2011). Montmorency
cherry juice reduces muscle damage caused by intensive strength exercise. Med Sci
Sports Exerc, 43(8), 1544-1551. doi: 10.1249/MSS.0b013e31820e5adc
Brancaccio, P., Lippi, G., & Maffulli, N. (2010). Biochemical markers of muscular
damage. Clin Chem Lab Med, 48(6), 757-767. doi: 10.1515/CCLM.2010.179
Brigitte, M., Schilte, C., Plonquet, A., Baba-Amer, Y., Henri, A., Charlier, C., . . . Chretien,
F. (2010). Muscle resident macrophages control the immune cell reaction in a
mouse model of notexin-induced myoinjury. Arthritis Rheum, 62(1), 268-279. doi:
10.1002/art.27183
Bruun, J. M., Lihn, A. S., Madan, A. K., Pedersen, S. B., Schiott, K. M., Fain, J. N., &
Richelsen, B. (2004). Higher production of IL-8 in visceral vs. subcutaneous
adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol
Endocrinol Metab, 286(1), E8-13. doi: 10.1152/ajpendo.00269.2003
Brzycki, M. (1993). Strength testing - predicting a one-rep max from reps-to-fatigue. J
Phys Educ Recr Dance, 64, 88-90.
Buechler, C., Ritter, M., Orso, E., Langmann, T., Klucken, J., & Schmitz, G. (2000).
Regulation of scavenger receptor CD163 expression in human monocytes and
macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol, 67(1), 97-103.
Buford, T. W., Cooke, M. B., & Willoughby, D. S. (2009). Resistance exercise-induced
changes of inflammatory gene expression within human skeletal muscle. Eur J Appl
Physiol, 107(4), 463-471. doi: 10.1007/s00421-009-1145-z

134

Byrne, C., & Eston, R. (2002). The effect of exercise-induced muscle damage on isometric
and dynamic knee extensor strength and vertical jump performance. J Sports Sci,
20(5), 417-425. doi: 10.1080/026404102317366672
Calle, M. C., & Fernandez, M. L. (2010). Effects of resistance training on the inflammatory
response. Nutr Res Pract, 4(4), 259-269. doi: 10.4162/nrp.2010.4.4.259
Catoire, M., Mensink, M., Kalkhoven, E., Schrauwen, P., & Kersten, S. (2014).
Identification of human exercise-induced myokines using secretome analysis.
Physiol Genomics, 46(7), 256-267. doi: 10.1152/physiolgenomics.00174.2013
Chan, M. H., Carey, A. L., Watt, M. J., & Febbraio, M. A. (2004). Cytokine gene
expression in human skeletal muscle during concentric contraction: evidence that
IL-8, like IL-6, is influenced by glycogen availability. Am J Physiol Regul Integr
Comp Physiol, 287(2), R322-327. doi: 10.1152/ajpregu.00030.2004
Chazaud, B. (2014). Macrophages: supportive cells for tissue repair and regeneration.
Immunobiology, 219(3), 172-178. doi: 10.1016/j.imbio.2013.09.001
Cheng, M., Nguyen, M. H., Fantuzzi, G., & Koh, T. J. (2008). Endogenous interferongamma is required for efficient skeletal muscle regeneration. Am J Physiol Cell
Physiol, 294(5), C1183-1191. doi: 10.1152/ajpcell.00568.2007
Cheung, K., Hume, P., & Maxwell, L. (2003). Delayed onset muscle soreness : treatment
strategies and performance factors. Sports Med, 33(2), 145-164.
Chiva-Blanch, G., Urpi-Sarda, M., Llorach, R., Rotches-Ribalta, M., Guillen, M., Casas,
R., . . . Estruch, R. (2012). Differential effects of polyphenols and alcohol of red
wine on the expression of adhesion molecules and inflammatory cytokines related
to atherosclerosis: a randomized clinical trial. Am J Clin Nutr, 95(2), 326-334. doi:
10.3945/ajcn.111.022889
Clarkson, P. M., & Hubal, M. J. (2002). Exercise-induced muscle damage in humans. Am
J
Phys
Med
Rehabil,
81(11
Suppl),
S52-69.
doi:
10.1097/01.PHM.0000029772.45258.43
Clarkson, P. M., Kearns, A. K., Rouzier, P., Rubin, R., & Thompson, P. D. (2006). Serum
creatine kinase levels and renal function measures in exertional muscle damage.
Med Sci Sports Exerc, 38(4), 623-627. doi: 10.1249/01.mss.0000210192.49210.fc
Cros, J., Cagnard, N., Woollard, K., Patey, N., Zhang, S. Y., Senechal, B., . . . Geissmann,
F. (2010). Human CD14dim monocytes patrol and sense nucleic acids and viruses
135

via TLR7 and TLR8 receptors.
10.1016/j.immuni.2010.08.012

Immunity,

33(3),

375-386.

doi:

Crystal, N. J., Townson, D. H., Cook, S. B., & LaRoche, D. P. (2013). Effect of cryotherapy
on muscle recovery and inflammation following a bout of damaging exercise. Eur
J Appl Physiol, 113(10), 2577-2586. doi: 10.1007/s00421-013-2693-9
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., . . .
Fogelman, A. M. (1990). Minimally modified low density lipoprotein induces
monocyte chemotactic protein 1 in human endothelial cells and smooth muscle
cells. Proc Natl Acad Sci U S A, 87(13), 5134-5138.
Dale, D. C., Boxer, L., & Liles, W. C. (2008). The phagocytes: neutrophils and monocytes.
Blood, 112(4), 935-945. doi: 10.1182/blood-2007-12-077917
Damoiseaux, J. G., Dopp, E. A., Calame, W., Chao, D., MacPherson, G. G., & Dijkstra, C.
D. (1994). Rat macrophage lysosomal membrane antigen recognized by
monoclonal antibody ED1. Immunology, 83(1), 140-147.
Della Gatta, P. A., Cameron-Smith, D., & Peake, J. M. (2014). Acute resistance exercise
increases the expression of chemotactic factors within skeletal muscle. Eur J Appl
Physiol, 114(10), 2157-2167. doi: 10.1007/s00421-014-2936-4
Dijkstra, C. D., Dopp, E. A., Joling, P., & Kraal, G. (1985). The heterogeneity of
mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations
in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology,
54(3), 589-599.
Dill, D. B., & Costill, D. L. (1974). Calculation of percentage changes in volumes of blood,
plasma, and red cells in dehydration. J Appl Physiol, 37(2), 247-248.
Dimitrov, S., Shaikh, F., Pruitt, C., Green, M., Wilson, K., Beg, N., & Hong, S. (2013).
Differential TNF production by monocyte subsets under physical stress: blunted
mobilization of proinflammatory monocytes in prehypertensive individuals. Brain
Behav Immun, 27(1), 101-108. doi: 10.1016/j.bbi.2012.10.003
Dungey, M., Bishop, N. C., Young, H. M., Burton, J. O., & Smith, A. C. (2015). The
Impact of Exercising During Haemodialysis on Blood Pressure, Markers of Cardiac
Injury and Systemic Inflammation - Preliminary Results of a Pilot Study. Kidney
Blood Press Res, 40(6), 593-604. doi: 10.1159/000368535

136

Ehlers, M. R. (2000). CR3: a general purpose adhesion-recognition receptor essential for
innate immunity. Microbes Infect, 2(3), 289-294.
Evangelista, V., Manarini, S., Sideri, R., Rotondo, S., Martelli, N., Piccoli, A., . . . Cerletti,
C. (1999). Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers
protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of
PSGL-1 as a signaling molecule. Blood, 93(3), 876-885.
Finaud, J., Lac, G., & Filaire, E. (2006). Oxidative stress : relationship with exercise and
training. Sports Med, 36(4), 327-358.
Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., & Patel,
D. D. (1998). Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte
capture, firm adhesion, and activation under physiologic flow. J Exp Med, 188(8),
1413-1419.
Foussat, A., Coulomb-L'Hermine, A., Gosling, J., Krzysiek, R., Durand-Gasselin, I.,
Schall, T., . . . Emilie, D. (2000). Fractalkine receptor expression by T lymphocyte
subpopulations and in vivo production of fractalkine in human. Eur J Immunol,
30(1),
87-97.
doi:
10.1002/1521-4141(200001)30:1<87::AIDIMMU87>3.0.CO;2-7
Fragala, M. S., Kraemer, W. J., Mastro, A. M., Denegar, C. R., Volek, J. S., Hakkinen, K.,
. . . Maresh, C. M. (2011). Leukocyte beta2-adrenergic receptor expression in
response to resistance exercise. Med Sci Sports Exerc, 43(8), 1422-1432. doi:
10.1249/MSS.0b013e31820b88bc
Freidenreich, D. J., & Volek, J. S. (2012). Immune responses to resistance exercise. Exerc
Immunol Rev, 18, 8-41.
Futosi, K., Fodor, S., & Mocsai, A. (2013). Neutrophil cell surface receptors and their
intracellular signal transduction pathways. Int Immunopharmacol, 17(3), 638-650.
doi: 10.1016/j.intimp.2013.06.034
Gabriel, H. H., & Kindermann, W. (1998). Adhesion molecules during immune response
to exercise. Can J Physiol Pharmacol, 76(5), 512-523.
Gavrieli, R., Ashlagi-Amiri, T., Eliakim, A., Nemet, D., Zigel, L., Berger-Achituv, S., . . .
Wolach, B. (2008). The effect of aerobic exercise on neutrophil functions. Med Sci
Sports Exerc, 40(9), 1623-1628. doi: 10.1249/MSS.0b013e318176b963

137

Gerhardt, T., & Ley, K. (2015). Monocyte trafficking across the vessel wall. Cardiovasc
Res, 107(3), 321-330. doi: 10.1093/cvr/cvv147
Gonzalez, A. M., Fragala, M. S., Jajtner, A. R., Townsend, J. R., Wells, A. J., Beyer, K.
S., . . . Hoffman, J. R. (2014). Effects of beta-hydroxy-beta-methylbutyrate free
acid and cold water immersion on expression of CR3 and MIP-1beta following
resistance exercise. Am J Physiol Regul Integr Comp Physiol, 306(7), R483-489.
doi: 10.1152/ajpregu.00542.2013
Gordon, S., & Martinez, F. O. (2010). Alternative activation of macrophages: mechanism
and functions. Immunity, 32(5), 593-604. doi: 10.1016/j.immuni.2010.05.007
Graff, J. C., & Jutila, M. A. (2007). Differential regulation of CD11b on gammadelta T
cells and monocytes in response to unripe apple polyphenols. J Leukoc Biol, 82(3),
603-607. doi: 10.1189/jlb.0207125
Grage-Griebenow, E., Zawatzky, R., Kahlert, H., Brade, L., Flad, H., & Ernst, M. (2001).
Identification of a novel dendritic cell-like subset of CD64(+) / CD16(+) blood
monocytes. Eur J Immunol, 31(1), 48-56. doi: 10.1002/15214141(200101)31:1&#60;48::AID-IMMU48&#62;3.0.CO;2-5
Hammond, M. E., Lapointe, G. R., Feucht, P. H., Hilt, S., Gallegos, C. A., Gordon, C. A.,
. . . Tekamp-Olson, P. (1995). IL-8 induces neutrophil chemotaxis predominantly
via type I IL-8 receptors. J Immunol, 155(3), 1428-1433.
Hampton, M. B., Kettle, A. J., & Winterbourn, C. C. (1998). Inside the neutrophil
phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood, 92(9), 30073017.
Heimbeck, I., Hofer, T. P., Eder, C., Wright, A. K., Frankenberger, M., Marei, A., . . .
Ziegler-Heitbrock, L. (2010). Standardized single-platform assay for human
monocyte subpopulations: Lower CD14+CD16++ monocytes in females.
Cytometry A, 77(9), 823-830. doi: 10.1002/cyto.a.20942
Henson, D. A., Nieman, D. C., Nehlsen-Cannarella, S. L., Fagoaga, O. R., Shannon, M.,
Bolton, M. R., . . . Schilling, B. K. (2000). Influence of carbohydrate on cytokine
and phagocytic responses to 2 h of rowing. Med Sci Sports Exerc, 32(8), 13841389.
Herrlinger, K. A., Chirouzes, D. M., & Ceddia, M. A. (2015). Supplementation with a
polyphenolic blend improves post-exercise strength recovery and muscle soreness.
Food Nutr Res, 59, 30034. doi: 10.3402/fnr.v59.30034
138

Hirose, L., Nosaka, K., Newton, M., Laveder, A., Kano, M., Peake, J., & Suzuki, K. (2004).
Changes in inflammatory mediators following eccentric exercise of the elbow
flexors. Exerc Immunol Rev, 10, 75-90.
Hoffman, J. R. (2006). Norms for fitness, performance, and health. Champaign: Human
Kinetics.
Honda, H., Kimura, H., & Rostami, A. (1990). Demonstration and phenotypic
characterization of resident macrophages in rat skeletal muscle. Immunology, 70(2),
272-277.
Hong, S., & Mills, P. J. (2008). Effects of an exercise challenge on mobilization and surface
marker expression of monocyte subsets in individuals with normal vs. elevated
blood
pressure.
Brain
Behav
Immun,
22(4),
590-599.
doi:
10.1016/j.bbi.2007.12.003
Hristov, M., & Weber, C. (2011). Differential role of monocyte subsets in atherosclerosis.
Thromb Haemost, 106(5), 757-762. doi: 10.1160/TH11-07-0500
Ihalainen, J., Walker, S., Paulsen, G., Hakkinen, K., Kraemer, W. J., Hamalainen, M., . . .
Mero, A. A. (2014). Acute leukocyte, cytokine and adipocytokine responses to
maximal and hypertrophic resistance exercise bouts. Eur J Appl Physiol, 114(12),
2607-2616. doi: 10.1007/s00421-014-2979-6
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., . . . Yoshie, O.
(1997). Identification and molecular characterization of fractalkine receptor
CX3CR1, which mediates both leukocyte migration and adhesion. Cell, 91(4), 521530.
Jajtner, A. R., Fragala, M. S., Townsend, J. R., Gonzalez, A. M., Wells, A. J., Fukuda, D.
H., . . . Hoffman, J. R. (2014). Mediators of Monocyte Migration in Response to
Recovery Modalities following Resistance Exercise. Mediators of Inflammation.
Jajtner, A. R., Hoffman, J. R., Gonzalez, A. M., Worts, P. R., Fragala, M. S., & Stout, J.
R. (2015). Comparison of the effects of electrical stimulation and cold-water
immersion on muscle soreness after resistance exercise. J Sport Rehabil, 24(2), 99108. doi: 10.1123/jsr.2013-0113
Jordan, J., Beneke, R., Hutler, M., Veith, A., Luft, F. C., & Haller, H. (1999). Regulation
of MAC-1 (CD11b/CD18) expression on circulating granulocytes in endurance
runners. Med Sci Sports Exerc, 31(3), 362-367.

139

Jowko, E., Sacharuk, J., Balasinska, B., Ostaszewski, P., Charmas, M., & Charmas, R.
(2011). Green tea extract supplementation gives protection against exerciseinduced oxidative damage in healthy men. Nutr Res, 31(11), 813-821. doi:
10.1016/j.nutres.2011.09.020
Kansas, G. S. (1996). Selectins and their ligands: current concepts and controversies.
Blood, 88(9), 3259-3287.
Kawai, K., Tsuno, N. H., Kitayama, J., Okaji, Y., Yazawa, K., Asakage, M., . . . Nagawa,
H. (2004). Epigallocatechin gallate attenuates adhesion and migration of CD8+ T
cells by binding to CD11b. J Allergy Clin Immunol, 113(6), 1211-1217. doi:
10.1016/j.jaci.2004.02.044
Kawanishi, N., Mizokami, T., Niihara, H., Yada, K., & Suzuki, K. (2016). Macrophage
depletion by clodronate liposome attenuates muscle injury and inflammation
following exhaustive exercise. Biochemistry and Biophysics Reports, 5, 146-151.
Kerksick, C. M., Kreider, R. B., & Willoughby, D. S. (2010). Intramuscular adaptations to
eccentric exercise and antioxidant supplementation. Amino Acids, 39(1), 219-232.
doi: 10.1007/s00726-009-0432-7
Kittner, J. M., Jacobs, R., Pawlak, C. R., Heijnen, C. J., Schedlowski, M., & Schmidt, R.
E. (2002). Adrenaline-induced immunological changes are altered in patients with
rheumatoid arthritis. Rheumatology (Oxford), 41(9), 1031-1039.
Kolaczkowska, E., & Kubes, P. (2013). Neutrophil recruitment and function in health and
inflammation. Nat Rev Immunol, 13(3), 159-175. doi: 10.1038/nri3399
Kurokawa, Y., Shinkai, S., Torii, J., Hino, S., & Shek, P. N. (1995). Exercise-induced
changes in the expression of surface adhesion molecules on circulating
granulocytes and lymphocytes subpopulations. Eur J Appl Physiol Occup Physiol,
71(2-3), 245-252.
LaVoy, E. C., Bollard, C. M., Hanley, P. J., O'Connor, D. P., Lowder, T. W., Bosch, J. A.,
& Simpson, R. J. (2015). A single bout of dynamic exercise by healthy adults
enhances the generation of monocyte-derived-dendritic cells. Cell Immunol,
295(1), 52-59. doi: 10.1016/j.cellimm.2015.02.007
Leonard, E. J., & Yoshimura, T. (1990). Human monocyte chemoattractant protein-1
(MCP-1). Immunol Today, 11(3), 97-101.

140

Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007). Getting to the site of
inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol, 7(9),
678-689. doi: 10.1038/nri2156
Lockhart, N. C., & Brooks, S. V. (2008). Neutrophil accumulation following passive
stretches contributes to adaptations that reduce contraction-induced skeletal muscle
injury in mice. J Appl Physiol (1985), 104(4), 1109-1115. doi:
10.1152/japplphysiol.00850.2007
Ludwig, A., Berkhout, T., Moores, K., Groot, P., & Chapman, G. (2002). Fractalkine is
expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and
is modulated by metalloproteinase activity. J Immunol, 168(2), 604-612.
Machin, D. R., Christmas, K. V., Chou, T., Hill, S. C., Van Pelt, D. W., Trombold, J. R.,
& Coyle, E. F. (2014). Effects of Differing Dosages of Pomegranate Juice
Supplementation after Eccentric Exercise. Physiology Journal, 2014.
Malm, C., Lenkei, R., & Sjodin, B. (1999). Effects of eccentric exercise on the immune
system in men. J Appl Physiol, 86(2), 461-468.
Malm, C., Nyberg, P., Engstrom, M., Sjodin, B., Lenkei, R., Ekblom, B., & Lundberg, I.
(2000). Immunological changes in human skeletal muscle and blood after eccentric
exercise and multiple biopsies. J Physiol, 529(1), 243-262.
Manach, C., Scalbert, A., Morand, C., Remesy, C., & Jimenez, L. (2004). Polyphenols:
food sources and bioavailability. Am J Clin Nutr, 79(5), 727-747.
Martin, N. R. W., & Lewis, M. P. (2012). Satellite cell activation and number following
acute and chronic exercise: a mini review. Cellular and Molecular Exercise
Physiology, 1(1), 1-5.
Mayhew, D. L., Thyfault, J. P., & Koch, A. J. (2005). Rest-interval length affects leukocyte
levels during heavy resistance exercise. J Strength Cond Res, 19(1), 16-22. doi:
10.1519/R-14113.1
McLennan, I. (1993). Resident macrophages (ED2- and ED3-positive) do not phagocytose
degenerating rat skeletal muscle fibers. Cell Tissue Research, 272, 193-196.
Merry, T. L., & Ristow, M. (2015). Do antioxidant supplements interfere with skeletal
muscle adaptation to exercise training? J Physiol. doi: 10.1113/JP270654

141

Miles, M. P., Leach, S. K., Kraemer, W. J., Dohi, K., Bush, J. A., & Mastro, A. M. (1998).
Leukocyte adhesion molecule expression during intense resistance exercise. J Appl
Physiol (1985), 84(5), 1604-1609.
Millet, G. Y., & Lepers, R. (2004). Alterations of neuromuscular function after prolonged
running, cycling and skiing exercises. Sports Med, 34(2), 105-116.
Mitchell, A. J., Roediger, B., & Weninger, W. (2014). Monocyte homeostasis and the
plasticity of inflammatory monocytes. Cell Immunol, 291(1-2), 22-31. doi:
10.1016/j.cellimm.2014.05.010
Montecucco, F., Steffens, S., Burger, F., Da Costa, A., Bianchi, G., Bertolotto, M., . . .
Ottonello, L. (2008). Tumor necrosis factor-alpha (TNF-alpha) induces integrin
CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3
(MIP-1alpha) on human neutrophils through defined signalling pathways. Cell
Signal, 20(3), 557-568. doi: 10.1016/j.cellsig.2007.11.008
Mosser, D. M., & Edwards, J. P. (2008). Exploring the full spectrum of macrophage
activation. Nat Rev Immunol, 8(12), 958-969. doi: 10.1038/nri2448
Myburgh, K. H. (2014). Polyphenol supplementation: benefits for exercise performance or
oxidative stress? Sports Med, 44 Suppl 1, S57-70. doi: 10.1007/s40279-014-01514
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo,
J. L., . . . Pittet, M. J. (2007). The healing myocardium sequentially mobilizes two
monocyte subsets with divergent and complementary functions. J Exp Med,
204(12), 3037-3047. doi: 10.1084/jem.20070885
Nguyen, H. X., & Tidball, J. G. (2003a). Interactions between neutrophils and
macrophages promote macrophage killing of rat muscle cells in vitro. J Physiol,
547(Pt 1), 125-132. doi: 10.1113/jphysiol.2002.031450
Nguyen, H. X., & Tidball, J. G. (2003b). Null mutation of gp91phox reduces muscle
membrane lysis during muscle inflammation in mice. J Physiol, 553(Pt 3), 833841. doi: 10.1113/jphysiol.2003.051912
Nicod, L. P. (1993). Cytokines. 1. Overview. Thorax, 48(6), 660-667.
Nielsen, H. G., & Lyberg, T. (2004). Long-distance running modulates the expression of
leucocyte and endothelial adhesion molecules. Scand J Immunol, 60(4), 356-362.
doi: 10.1111/j.0300-9475.2004.01486.x
142

Nieman, D. C., Davis, J. M., Brown, V. A., Henson, D. A., Dumke, C. L., Utter, A. C., . .
. McAnulty, L. S. (2004). Influence of carbohydrate ingestion on immune changes
after 2 h of intensive resistance training. J Appl Physiol (1985), 96(4), 1292-1298.
doi: 10.1152/japplphysiol.01064.2003
Nieman, D. C., Davis, J. M., Henson, D. A., Walberg-Rankin, J., Shute, M., Dumke, C. L.,
. . . McAnulty, L. S. (2003). Carbohydrate ingestion influences skeletal muscle
cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl Physiol (1985),
94(5), 1917-1925. doi: 10.1152/japplphysiol.01130.2002
Nieman, D. C., Gillitt, N. D., Knab, A. M., Shanely, R. A., Pappan, K. L., Jin, F., & Lila,
M. A. (2013). Influence of a polyphenol-enriched protein powder on exerciseinduced inflammation and oxidative stress in athletes: a randomized trial using a
metabolomics
approach.
PLoS
One,
8(8),
e72215.
doi:
10.1371/journal.pone.0072215
Nieman, D. C., Henson, D. A., Davis, J. M., Dumke, C. L., Gross, S. J., Jenkins, D. P., . .
. Mayer, E. P. (2007). Quercetin ingestion does not alter cytokine changes in
athletes competing in the Western States Endurance Run. J Interferon Cytokine Res,
27(12), 1003-1011. doi: 10.1089/jir.2007.0050
Nieman, D. C., Henson, D. A., Gross, S. J., Jenkins, D. P., Davis, J. M., Murphy, E. A., . .
. Mayer, E. P. (2007). Quercetin reduces illness but not immune perturbations after
intensive exercise. Med Sci Sports Exerc, 39(9), 1561-1569. doi:
10.1249/mss.0b013e318076b566
Nieman, D. C., Henson, D. A., Sampson, C. S., Herring, J. L., Suttles, J., Conley, M., . . .
Davis, J. M. (1995). The acute immune response to exhaustive resistance exercise.
Int J Sports Med, 16(5), 322-328. doi: 10.1055/s-2007-973013
Novak, M. L., & Koh, T. J. (2013). Macrophage phenotypes during tissue repair. J Leukoc
Biol, 93(6), 875-881. doi: 10.1189/jlb.1012512
O'Fallon, K. S., Kaushik, D., Michniak-Kohn, B., Dunne, C. P., Zambraski, E. J., &
Clarkson, P. M. (2012). Effects of quercetin supplementation on markers of muscle
damage and inflammation after eccentric exercise. Int J Sport Nutr Exerc Metab,
22(6), 430-437.
Panza, V. S., Wazlawik, E., Ricardo Schutz, G., Comin, L., Hecht, K. C., & da Silva, E. L.
(2008). Consumption of green tea favorably affects oxidative stress markers in
weight-trained men. Nutrition, 24(5), 433-442. doi: 10.1016/j.nut.2008.01.009

143

Parkin, J., & Cohen, B. (2001). An overview of the immune system. Lancet, 357(9270),
1777-1789. doi: 10.1016/S0140-6736(00)04904-7
Paulsen, G., Benestad, H. B., Strom-Gundersen, I., Morkrid, L., Lappegard, K. T., &
Raastad, T. (2005). Delayed leukocytosis and cytokine response to high-force
eccentric exercise. Med Sci Sports Exerc, 37(11), 1877-1883.
Paulsen, G., Crameri, R., Benestad, H. B., Fjeld, J. G., Morkrid, L., Hallen, J., & Raastad,
T. (2010). Time course of leukocyte accumulation in human muscle after eccentric
exercise.
Med
Sci
Sports
Exerc,
42(1),
75-85.
doi:
10.1249/MSS.0b013e3181ac7adb
Paulsen, G., Hamarsland, H., Cumming, K. T., Johansen, R. E., Hulmi, J. J., Borsheim, E.,
. . . Raastad, T. (2014). Vitamin C and E supplementation alters protein signalling
after a strength training session, but not muscle growth during 10 weeks of training.
J Physiol, 592(24), 5391-5408. doi: 10.1113/jphysiol.2014.279950
Peake, J., Nosaka, K., & Suzuki, K. (2005). Characterization of inflammatory responses to
eccentric exercise in humans. Exerc Immunol Rev, 11, 64-85.
Peake, J. M., Suzuki, K., Hordern, M., Wilson, G., Nosaka, K., & Coombes, J. S. (2005).
Plasma cytokine changes in relation to exercise intensity and muscle damage. Eur
J Appl Physiol, 95(5-6), 514-521. doi: 10.1007/s00421-005-0035-2
Peake, J. M., Suzuki, K., Wilson, G., Hordern, M., Nosaka, K., Mackinnon, L., &
Coombes, J. S. (2005). Exercise-induced muscle damage, plasma cytokines, and
markers of neutrophil activation. Med Sci Sports Exerc, 37(5), 737-745.
Pedersen, B. K. (2000). Special feature for the Olympics: effects of exercise on the immune
system: exercise and cytokines. Immunol Cell Biol, 78(5), 532-535. doi:
10.1111/j.1440-1711.2000.t01-11-.x
Pedersen, B. K., Akerstrom, T. C., Nielsen, A. R., & Fischer, C. P. (2007). Role of
myokines in exercise and metabolism. J Appl Physiol (1985), 103(3), 1093-1098.
doi: 10.1152/japplphysiol.00080.2007
Pilling, D., Fan, T., Huang, D., Kaul, B., & Gomer, R. H. (2009). Identification of markers
that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and
fibroblasts. PLoS One, 4(10), e7475. doi: 10.1371/journal.pone.0007475

144

Pimorady-Esfahani, A., Grounds, M. D., & McMenamin, P. G. (1997). Macrophages and
dendritic cells in normal and regenerating murine skeletal muscle. Muscle Nerve,
20(2), 158-166.
Pizza, F. X., Davis, B. H., Henrickson, S. D., Mitchell, J. B., Pace, J. F., Bigelow, N., . . .
Naglieri, T. (1996). Adaptation to eccentric exercise: effect on CD64 and
CD11b/CD18 expression. J Appl Physiol, 80(1), 47-55.
Pizza, F. X., Peterson, J. M., Baas, J. H., & Koh, T. J. (2005). Neutrophils contribute to
muscle injury and impair its resolution after lengthening contractions in mice. J
Physiol, 562(Pt 3), 899-913. doi: 10.1113/jphysiol.2004.073965
Poehlmann, H., Schefold, J. C., Zuckermann-Becker, H., Volk, H. D., & Meisel, C. (2009).
Phenotype changes and impaired function of dendritic cell subsets in patients with
sepsis: a prospective observational analysis. Crit Care, 13(4), R119. doi:
10.1186/cc7969
Polfliet, M. M., Fabriek, B. O., Daniels, W. P., Dijkstra, C. D., & van den Berg, T. K.
(2006). The rat macrophage scavenger receptor CD163: expression, regulation and
role in inflammatory mediator production. Immunobiology, 211(6-8), 419-425. doi:
10.1016/j.imbio.2006.05.015
Power, C. P., Wang, J. H., Manning, B., Kell, M. R., Aherne, N. J., Wu, Q. D., & Redmond,
H. P. (2004). Bacterial lipoprotein delays apoptosis in human neutrophils through
inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2. J Immunol,
173(8), 5229-5237.
Radom-Aizik, S., Zaldivar, F., Leu, S. Y., Galassetti, P., & Cooper, D. M. (2008). Effects
of 30 min of aerobic exercise on gene expression in human neutrophils. J Appl
Physiol, 104(1), 236-243. doi: 10.1152/japplphysiol.00872.2007
Radom-Aizik, S., Zaldivar, F. P., Jr., Haddad, F., & Cooper, D. M. (2014). Impact of brief
exercise on circulating monocyte gene and microRNA expression: implications for
atherosclerotic vascular disease. Brain Behav Immun, 39, 121-129. doi:
10.1016/j.bbi.2014.01.003
Ramel, A., Wagner, K. H., & Elmadfa, I. (2003). Acute impact of submaximal resistance
exercise on immunological and hormonal parameters in young men. J Sports Sci,
21(12), 1001-1008. doi: 10.1080/02640410310001641395
Ramel, A., Wagner, K. H., & Elmadfa, I. (2004). Correlations between plasma
noradrenaline concentrations, antioxidants, and neutrophil counts after submaximal
145

resistance exercise in men.
10.1136/bjsm.2003.007666

Br

J

Sports

Med,

38(5),

E22.

doi:

Ramos, M. V., Fernandez, G. C., Brando, R. J., Panek, C. A., Bentancor, L. V., Landoni,
V. I., . . . Palermo, M. S. (2010). Interleukin-10 and interferon-gamma modulate
surface expression of fractalkine-receptor (CX(3)CR1) via PI3K in monocytes.
Immunology, 129(4), 600-609. doi: 10.1111/j.1365-2567.2009.03181.x
Ribeiro, R. A., Flores, C. A., Cunha, F. Q., & Ferreira, S. H. (1991). IL-8 causes in vivo
neutrophil migration by a cell-dependent mechanism. Immunology, 73(4), 472-477.
Rigamonti, E., Touvier, T., Clementi, E., Manfredi, A. A., Brunelli, S., & Rovere-Querini,
P. (2013). Requirement of inducible nitric oxide synthase for skeletal muscle
regeneration after acute damage. J Immunol, 190(4), 1767-1777. doi:
10.4049/jimmunol.1202903
Rollins, B. J. (1997). Chemokines. Blood, 90(3), 909-928.
Rollins, B. J., Yoshimura, T., Leonard, E. J., & Pober, J. S. (1990). Cytokine-activated
human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP1/JE. Am J Pathol, 136(6), 1229-1233.
Rosen, H., & Gordon, S. (1987). Monoclonal antibody to the murine type 3 complement
receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell
recruitment in vivo. J Exp Med, 166(6), 1685-1701.
Ross, M. L., Halson, S. L., Suzuki, K., Garnham, A., Hawley, J. A., Cameron-Smith, D.,
& Peake, J. M. (2010). Cytokine responses to carbohydrate ingestion during
recovery from exercise-induced muscle injury. J Interferon Cytokine Res, 30(5),
329-337. doi: 10.1089/jir.2009.0079
Rossol, M., Kraus, S., Pierer, M., Baerwald, C., & Wagner, U. (2012). The CD14(bright)
CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes
expansion of the Th17 cell population. Arthritis Rheum, 64(3), 671-677. doi:
10.1002/art.33418
Rot, A., & von Andrian, U. H. (2004). Chemokines in innate and adaptive host defense:
basic chemokinese grammar for immune cells. Annu Rev Immunol, 22, 891-928.
doi: 10.1146/annurev.immunol.22.012703.104543

146

Roussel, M., Benard, C., Ly-Sunnaram, B., & Fest, T. (2010). Refining the white blood
cell differential: the first flow cytometry routine application. Cytometry A, 77(6),
552-563. doi: 10.1002/cyto.a.20893
Saclier, M., Yacoub-Youssef, H., Mackey, A. L., Arnold, L., Ardjoune, H., Magnan, M., .
. . Chazaud, B. (2013). Differentially activated macrophages orchestrate myogenic
precursor cell fate during human skeletal muscle regeneration. Stem Cells, 31(2),
384-396. doi: 10.1002/stem.1288
Sadik, C. D., Kim, N. D., & Luster, A. D. (2011). Neutrophils cascading their way to
inflammation. Trends Immunol, 32(10), 452-460. doi: 10.1016/j.it.2011.06.008
Saxton, J. M., Claxton, D., Winter, E., & Pockley, A. G. (2003). Peripheral blood leucocyte
functional responses to acute eccentric exercise in humans are influenced by
systemic stress, but not by exercise-induced muscle damage. Clin Sci (Lond),
104(1), 69-77. doi: 10.1042/
Scalbert, A., Johnson, I. T., & Saltmarsh, M. (2005). Polyphenols: antioxidants and
beyond. Am J Clin Nutr, 81(1 Suppl), 215S-217S.
Schraufstatter, I. U., Chung, J., & Burger, M. (2001). IL-8 activates endothelial cell
CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung
Cell Mol Physiol, 280(6), L1094-1103.
Semerad, C. L., Liu, F., Gregory, A. D., Stumpf, K., & Link, D. C. (2002). G-CSF is an
essential regulator of neutrophil trafficking from the bone marrow to the blood.
Immunity, 17(4), 413-423.
Shantsila, E., Tapp, L. D., Wrigley, B. J., Montoro-Garcia, S., Ghattas, A., Jaipersad, A.,
& Lip, G. Y. (2012). The effects of exercise and diurnal variation on monocyte
subsets and monocyte-platelet aggregates. Eur J Clin Invest, 42(8), 832-839. doi:
10.1111/j.1365-2362.2012.02656.x
Simonson, S. R., & Jackson, C. G. (2004). Leukocytosis occurs in response to resistance
exercise in men. J Strength Cond Res, 18(2), 266-271. doi: 10.1519/R-12572.1
Simpson, R. J., McFarlin, B. K., McSporran, C., Spielmann, G., o Hartaigh, B., & Guy, K.
(2009). Toll-like receptor expression on classic and pro-inflammatory blood
monocytes after acute exercise in humans. Brain Behav Immun, 23(2), 232-239.
doi: 10.1016/j.bbi.2008.09.013

147

Soehnlein, O., Lindbom, L., & Weber, C. (2009). Mechanisms underlying neutrophilmediated monocyte recruitment. Blood, 114(21), 4613-4623. doi: 10.1182/blood2009-06-221630
Song, E., Ouyang, N., Horbelt, M., Antus, B., Wang, M., & Exton, M. S. (2000). Influence
of alternatively and classically activated macrophages on fibrogenic activities of
human fibroblasts. Cell Immunol, 204(1), 19-28. doi: 10.1006/cimm.2000.1687
Steppich, B., Dayyani, F., Gruber, R., Lorenz, R., Mack, M., & Ziegler-Heitbrock, H. W.
(2000). Selective mobilization of CD14(+)CD16(+) monocytes by exercise. Am J
Physiol Cell Physiol, 279(3), C578-586.
Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., & Suttles, J. (2005).
Macrophages sequentially change their functional phenotype in response to
changes in microenvironmental influences. J Immunol, 175(1), 342-349.
Stromberg, A., Olsson, K., Dijksterhuis, J. P., Rullman, E., Schulte, G., & Gustafsson, T.
(2016). CX3CL1-a macrophage chemoattractant induced by a single bout of
exercise in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol,
310(3), R297-304. doi: 10.1152/ajpregu.00236.2015
Summers, C., Rankin, S. M., Condliffe, A. M., Singh, N., Peters, A. M., & Chilvers, E. R.
(2010). Neutrophil kinetics in health and disease. Trends Immunol, 31(8), 318-324.
doi: 10.1016/j.it.2010.05.006
Szmitko, P. E., Wang, C. H., Weisel, R. D., de Almeida, J. R., Anderson, T. J., & Verma,
S. (2003). New markers of inflammation and endothelial cell activation: Part I.
Circulation, 108(16), 1917-1923. doi: 10.1161/01.CIR.0000089190.95415.9F
Takano, K., Nakaima, K., Nitta, M., Shibata, F., & Nakagawa, H. (2004). Inhibitory effect
of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil
chemotaxis in vitro and in vivo. J Agric Food Chem, 52(14), 4571-4576. doi:
10.1021/jf0355194
Tallone, T., Turconi, G., Soldati, G., Pedrazzini, G., Moccetti, T., & Vassalli, G. (2011).
Heterogeneity of human monocytes: an optimized four-color flow cytometry
protocol for analysis of monocyte subsets. Journal of Cardiovascular Translational
Research, 4(2), 211-219. doi: 10.1007/s12265-011-9256-4
Tan, S. M. (2012). The leucocyte beta2 (CD18) integrins: the structure, functional
regulation and signalling properties. Biosci Rep, 32(3), 241-269. doi:
10.1042/BSR20110101
148

Tapp, L. D., Shantsila, E., Wrigley, B. J., Pamukcu, B., & Lip, G. Y. (2012). The
CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients
with ST-elevation myocardial infarction. J Thromb Haemost, 10(7), 1231-1241.
doi: 10.1111/j.1538-7836.2011.04603.x
Teixeira, C. F., Zamuner, S. R., Zuliani, J. P., Fernandes, C. M., Cruz-Hofling, M. A.,
Fernandes, I., . . . Gutierrez, J. M. (2003). Neutrophils do not contribute to local
tissue damage, but play a key role in skeletal muscle regeneration, in mice injected
with Bothrops asper snake venom. Muscle Nerve, 28(4), 449-459. doi:
10.1002/mus.10453
Tidball, J. G. (2005). Inflammatory processes in muscle injury and repair. Am J Physiol
Regul Integr Comp Physiol, 288(2), R345-353. doi: 10.1152/ajpregu.00454.2004
Tidball, J. G., & Villalta, S. A. (2010). Regulatory interactions between muscle and the
immune system during muscle regeneration. Am J Physiol Regul Integr Comp
Physiol, 298(5), R1173-1187. doi: 10.1152/ajpregu.00735.2009
Tidball, J. G., & Wehling-Henricks, M. (2007). Macrophages promote muscle membrane
repair and muscle fibre growth and regeneration during modified muscle loading in
mice in vivo. J Physiol, 578(Pt 1), 327-336. doi: 10.1113/jphysiol.2006.118265
Tidball, J. G., & Welc, S. S. (2015). Macrophage-Derived IGF-1 Is a Potent Coordinator
of Myogenesis and Inflammation in Regenerating Muscle. Mol Ther, 23(7), 11341135. doi: 10.1038/mt.2015.97
Tonkin, J., Temmerman, L., Sampson, R. D., Gallego-Colon, E., Barberi, L., Bilbao, D., .
. . Rosenthal, N. (2015). Monocyte/Macrophage-derived IGF-1 Orchestrates
Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization. Mol
Ther, 23(7), 1189-1200. doi: 10.1038/mt.2015.66
Turner, S. L., Mangnall, D., Bird, N. C., Blair-Zajdel, M. E., & Bunning, R. A. (2010).
Effects of pro-inflammatory cytokines on the production of soluble fractalkine and
ADAM17 by HepG2 cells. J Gastrointestin Liver Dis, 19(3), 265-271.
Urra, X., Villamor, N., Amaro, S., Gomez-Choco, M., Obach, V., Oleaga, L., . . .
Chamorro, A. (2009). Monocyte subtypes predict clinical course and prognosis in
human stroke. J Cereb Blood Flow Metab, 29(5), 994-1002. doi:
10.1038/jcbfm.2009.25
Urso, M. L., & Clarkson, P. M. (2003). Oxidative stress, exercise, and antioxidant
supplementation. Toxicology, 189(1-2), 41-54.
149

Van Craenenbroeck, A. H., Van Ackeren, K., Hoymans, V. Y., Roeykens, J., Verpooten,
G. A., Vrints, C. J., . . . Van Craenenbroeck, E. M. (2014). Acute Exercise-Induced
Response of Monocyte Subtypes in Chronic Heart and Renal Failure. Mediators of
Inflammation. doi: Artn 216534
10.1155/2014/216534
van Eeden, S. F., Granton, J., Hards, J. M., Moore, B., & Hogg, J. C. (1999). Expression
of the cell adhesion molecules on leukocytes that demarginate during acute
maximal exercise. J Appl Physiol, 86(3), 970-976.
Van Velzen, A. G., Da Silva, R. P., Gordon, S., & Van Berkel, T. J. (1997).
Characterization of a receptor for oxidized low-density lipoproteins on rat Kupffer
cells: similarity to macrosialin. Biochem J, 322 ( Pt 2), 411-415.
Vassilakopoulos, T., Karatza, M. H., Katsaounou, P., Kollintza, A., Zakynthinos, S., &
Roussos, C. (2003). Antioxidants attenuate the plasma cytokine response to
exercise in humans. J Appl Physiol (1985), 94(3), 1025-1032. doi:
10.1152/japplphysiol.00735.2002
Weber, C., Erl, W., & Weber, P. C. (1995). Enhancement of monocyte adhesion to
endothelial cells by oxidatively modified low-density lipoprotein is mediated by
activation of CD11b. Biochem Biophys Res Commun, 206(2), 621-628. doi:
10.1006/bbrc.1995.1088
Wells, A. J., Hoffman, J. R., Jajtner, A. R., Varanoske, A. N., Church, D. D., Gonzalez, A.
M., . . . Stout, J. R. (2016). Monocyte Recruitment following High-Intensity and
High-Volume Resistance Exercise. Med Sci Sports Exerc. doi:
10.1249/MSS.0000000000000878
Wong, K. L., Tai, J. J., Wong, W. C., Han, H., Sem, X., Yeap, W. H., . . . Wong, S. C.
(2011). Gene expression profiling reveals the defining features of the classical,
intermediate, and nonclassical human monocyte subsets. Blood, 118(5), e16-31.
doi: 10.1182/blood-2010-12-326355
Wong, K. L., Yeap, W. H., Tai, J. J., Ong, S. M., Dang, T. M., & Wong, S. C. (2012). The
three human monocyte subsets: implications for health and disease. Immunol Res,
53(1-3), 41-57. doi: 10.1007/s12026-012-8297-3
Yadav, A., Saini, V., & Arora, S. (2010). MCP-1: chemoattractant with a role beyond
immunity: a review. Clin Chim Acta, 411(21-22), 1570-1579. doi:
10.1016/j.cca.2010.07.006
150

Yang, J., Zhang, L., Yu, C., Yang, X. F., & Wang, H. (2014). Monocyte and macrophage
differentiation: circulation inflammatory monocyte as biomarker for inflammatory
diseases. Biomark Res, 2(1), 1. doi: 10.1186/2050-7771-2-1
Zawada, A. M., Rogacev, K. S., Rotter, B., Winter, P., Marell, R. R., Fliser, D., & Heine,
G. H. (2011). SuperSAGE evidence for CD14++CD16+ monocytes as a third
monocyte subset. Blood, 118(12), e50-61. doi: 10.1182/blood-2011-01-326827
Zhu, L., Yin, Y. G., Zhou, R. F., Lin, J., Li, J. M., & Ye, J. (2015). Changes of monocyte
subsets in patients with acute coronary syndrome and correlation with myocardial
injury markers. International Journal of Clinical and Experimental Pathology,
8(6), 7266-7271.
Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., . . . Lutz,
M. B. (2010). Nomenclature of monocytes and dendritic cells in blood. Blood,
116(16), e74-80.
Ziegler-Heitbrock, L., & Hofer, T. P. (2013). Toward a refined definition of monocyte
subsets. Front Immunol, 4, 23. doi: 10.3389/fimmu.2013.00023
Zouaoui Boudjeltia, K., Moguilevsky, N., Legssyer, I., Babar, S., Guillaume, M., Delree,
P., . . . Remacle, C. (2004). Oxidation of low density lipoproteins by
myeloperoxidase at the surface of endothelial cells: an additional mechanism to
subendothelium oxidation. Biochem Biophys Res Commun, 325(2), 434-438. doi:
10.1016/j.bbrc.2004.10.049

151

